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Enzymes activities belonging mainly to three systems
were determined in muscles from two animal models of muscle
atrophy. The first model is alcoholic myopathy. The other
is surgical denervation. In the denervation model, the
effect of a 13-agonist, clenbuterol, was also studied.
Clenbuterol has been reported to ameliorate denervation
induced atrophy. The three enzyme systems investigated were
lysosomal enzymes including proteinases, free radical
scavenging enzymes and energy metabolizing enzymes.
In alcoholic myopathy, activities of the lysosomal
enzymes, cathepsin B and acid phosphatase, increased in
soleus muscle only. Alkaline phosphatase activity was also
found to be increased'in soleus. These provide evidences
that it is mainly the slow twitch fibers, the main
components of soleus, which undergo atrophy after ethanol
treatment. For free radical scavenging enzymes, soleus
showed a pattern different from that of the other muscles.
Unchanged activities were found in coleus while increased
ca.talase and decreased superoxide dismutase activity were
found in other muscles studied. The change in activities of
these enzymes may serve as a protective mechanism for the
alcohol induced damage. As for energy metabolism, soleus
shifted from oxidative metabolism to anaerobic glycolysis.
After denervation, muscle weights decreased.
Clenbuterol treatment restored the weight of muscles, with
2the least response in EDL. Here, a fiber type specific
effect was also found. Enzymes of energy metabolism, both
in anaerobic glycolysis and in oxidative metabolism, were
decreased after denervation. Clenbuterol reversed the
change in MDH activity in all muscles studied and reversed
the LDH activity mainly in slow twitch muscles. The effect
.of clenbuterol was specific to denervated muscles. The
muscle type specific and denervation specific effect was
also found in the activities of proteinases and free radical
scavenging enzymes. In normal muscles treated with
clenbuterol, only soleus under long term treatment showed a
lowered proteinase activity. In denervated muscles,
proteinase activities were increased. Clenbuterol had its
ameliorative effect only in denervated fast twitch muscle.
Lipid peroxide content in muscles of adult rats was not
affected by denervation. It seems that lipid peroxidation
may not be involved in the denervation induced damage in
adult rats. However, superoxide 'dismutase activities
increased only in denervated fast twitch muscles. This
suggests that active radical species may be involved. This
also proposed-that denervation exerts its damaging effects
in different types of muscle types through diverse
mechanisms. For all muscles examined, a marked increase in
catalase activity was found and this was almost completely
restored by clenbuterol treatment.
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1.1 Muscle and Nerve
In animals, muscles have a large number of
physiological functions. In vertebrate, there are three main
classes of muscles that are characterized by both their
appearance in the light microscope and their mode of
innervation (Squire, 1986). They are the skeletal muscles,
the smooth muscles and the cardiac muscles. Approximately
40 per cent of the body is made up of skeletal muscles and
another 10 per cent is smooth and cardiac muscles (Guyton,
1987). Skeletal muscle comprises the greatest mass of
somatic musculature. Contraction of skeletal muscle can be
consciously controlled. For this reason, skeletal muscle is
also classified as the voluntary muscle while smooth and
cardiac muscles are referred to be involuntary muscles.
During normal behavior, it is the interaction of peripheral
nerves, the myoneuronal junctions and skeletal muscles with
each other to bring about the contraction and relaxation of
a muscle. It is therefore of paramount importance to
understand the relationship between muscles and nerves.
1.1.1 Neuron and Nerve
Neuron is the basic building block of the nervous'
system. Its specialized function is to receive and transmit
message in the form of neural impulses. A typical motor
neuron has a few processes called dendrites which extend out
from the cell body and arborize extensively. It has also a
single, elongated structure of cytoplasmic extension called
axon. Axon ends in a number of synaptic knobs. These knobs
contain granules or vesicles in which the synaptic
transmitter secreted by the nerve is stored (Ganong, 1981).
Dendrite and axon differ in their function by that dendrite
accepts the signals from other neurons while axon conducts
impulse away from the dendrite zone. Probably because it is
so long, an axon is often referred to as a nerve fiber.
In essentially all cells of the body, electrical
potentials exist across the membrane. This is called the
resting potential. In a neuron, as well as in. a muscle
cell, it amounts to about -40mV to -90mV (Guyton, 1987). It
is the result of a slight excess of positive ions outside
the cell membrane and a slight excess of negative ions
inside the membrane. Although most cells have a electrical
potential across the cell membrane, only some are
excitable— that is, capable of self-generation of
electrochemical impulses at their membranes and, in some
instances, employment of these impulses to transmit signal
along the membranes. The most well-known excitable cells
are the neurons and muscle cells. An electrical, chemical,
or mechanical stimulus may alter resting potential of neuron
by increasing the permeability of the membrane to sodium and
cause depolarization. If the neuron membrane is only
slightly stimulated, only a local disturbance may occur in
the membrane. However, if the stimulus is sufficiently
strong it may result in an action potential— that is, the
0'
propagation of a neural impulse. Actually, a neural impulse
is transmitted as a wave of depolarization that travels down
the neuron. For neuron, the impulse is usually transmitted
along the membrane from dendrite through the cell body to
the axon at which chemical substance or electrical stimulus
will be release and stimulate the following cells. In
muscle cells, the signal will at last be converted into the
contraction of the cells.
1.1.2 Skeletal Muscle
Muscle cells, like neurons, can be excited to produce
an action potential that is transmitted along their cell
membrane. They contain contractile proteins and, unlike
neurons, they have a mechanism that can be activated by the
t•
action potential.
Skeletal muscle is made up of individual muscle fibers
which are the building blocks of the muscular system.
Most skeletal muscles begin and end in tendons, and the
muscle fibers are arranged in parallel between the tendious
ends so that the force of contraction of the units is
«
additive. Each muscle fiber is a single cell,
multinucleated, long, and cylindrical in shape.
The muscle fibers are made up of fibrils, and the
fibrils are divisible into individual filaments. The
filaments are made up of the contractile proteins (Figure 1.
1). For the special array of filaments in the fibrils,
cross-striations can be observed on the muscle fibers.
Muscle contains the proteins myosin, actin, tropomyosin
and troponin. Troponin is made up of 3 subunits, troponin
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Figure 1.1 The structure of a skeletal muscle fiber (From
Solomon, E.P. and Davis, P.W.: Human anatomy
and physiology Saunders College Publishing:
191-210, 1983.
contractile proteins is shown in Figure 1.2. It is
suggested that M-line and Z-line organize the array of
contractile proteins and the degradation of these lines
causes the disorder of the filament.
The muscle fibers are surrounded by the sarcotubular
system, which is made up of the transverse tubular system (T
system) and a sarcoplasmic reticulum. The T system of the
transverse tubules is continuous with the membrane of the
muscle fibers and forms a grid perforated by the individual
muscle fibrils. Calcium ions are normally stored in the
cisterna of the sarcoplasmic reticulum. The action
potential spreads via the transverse tubules and release the
••
calcium ions. The released calcium ions initiate the
contraction of the muscle. Calcium ion is then pumped into
the sarcoplasmic reticulum, and the muscle relax.
1.1.3 The Functional Nervous System
The motor nerve fibers which innepvate striated
voluntary muscles except those in the head are axons of
cells in the anterior grey matter of the spinal cord
(Goodanlrl nrl P!h=»r=; hp i ri. 19 7 7 1.
The functional junction of nerve and muscle cell is
called the myoneural junction or neuromuscular junction. It
is also referred to be the motor end-plate. It is located
the midpoint of the fiber.
When a nerve impulse reaches the ends of -the nerve
cell, it induces the release of a transmitter substance. In
voluntary muscle-nerve junctions this transmitter is
Figure 1.2 Top: The band pattern of a myofibril. Middle
left: Arrangement of thin (actin) and thick
(myosin) filaments in skeletal muscle. I and. A
represent a cross section through the I band and
the lateral portion of the A band, respectively.
Middle right: Detail of structure of myosin and
actin. Bottom: Diagrammatic representation of
the arrangement of actin, tropomyosin, and the 3
subunits of troponin (I, C, and T). (From
Bowman, W.C. and Rand, M.J.: Textbook of
pharmacology 2nd edition, Balckwell Scientific
Publications, 1980 and Ganong, W.F.: Review of
Medical Physiology 10th edition, Maruzen Asian
Edition, Lange Medical Publications, 1981)
acetylcholine. It rapidly diffuses across the myoneura:
cleft, and when it reaches the muscle cell it almost
immediately induces a temporary electrical depolarization o:
the muscle cell membrane. The depolarization travels dowi
the surface of the muscle cell like a wave and at last b
conveyed to the contractile elements within the muscle eel'
through the T system (Solomon and Davis, 1983).
Myoneural junctions do not spread all over the muscle
but are usually concentrated in confined zones. This zone
is the junctional region and possesses properties different
to the other regions of the surface of muscle cell.
Antigenic and ligand binding affinity differences between
junctional and extrajunctional cholinergic receptors have
been re ported (Almon and Appel, 1976).
1.1.4 The Motor Unit
Within a muscle, the axon of a single motor nerve cell
arborizes into many terminal branches. Each branch is
attached to an individual muscle fiber. The branching of
the axon permits a single neuron to stimulate a group of
muscle fibers. The functional unit of the neuromuscular
system is the motor unit; it consists of the anterior horn
cell, its axon and all the muscle fibers innervated by that
axon. it was indicated that the fibers which belong to a
9iven motor unit are homogenous histochemically. Although
there may be considerable intermingling of fibers of
different units in a muscle, it appears that there is no
overlapping of fiber types within the single motor unit
1.2 Structural Refinements in Vertebrate Muscles: Fiber
Types
1.2.1 Different Types of Muscle Fibers
1.2.1.1 Tonic and Twitch Muscles
Vertebrate skeletal muscle can be divided into two main
types, tonic and twitch (or phasic, tetanic) types,
depending on their mode of innervation and response (Squire,
1986; Squire, 1981). Tonic muscles are multiterminally
innervated, whereas twitch muscles are stimulated by a
single motor nerve ending. The twitch muscle, like the
nerve membrane, shows an all-or-none response, while the
tonic muscle gives response graded according to the
frequency of stimulus of the nerve.
Electron microscopy has shown that the most important
structural difference between the two types of fibers
relates to their transverse tubular systems and sarcoplasmic
reticula (Bowman, 1980). Tonic muscles respond to
excitation with a slow and maintained shortening or tension
increase, in contrast to the rapid and brief contractile
response of twitch muscle fiber. The different arrangements
and numbers of contacts between t-tubules and sarcoplasmic
reticulum in the two types of fibers are compatible with
their different contractile velocities.
In mammals the twitch muscles predominate. Tonic
muscles occurs principally in the head and neck region: in
the eye, the voice box, and the ear. Almost all other
skeletal muscles are twitch muscles. In this thesis, the
focus is on the twitch muscles.
1.2.1.2 Past Twitch and Slow Twitch Fibers
Although almost all of the muscles in mammals are
twitch muscles, there is still a considerable range of
contractile response given by the skeletal muscles. One of
the main reasons is that different muscles contain varying
proportions of individual fiber types that have distinct
properties. The twitch fibers can be classified into three
categories on the basis of three criteria, (1) the
contraction time.of the fiber relative to others within the
same animal, (2) glycolytic capacity, and (3) oxidative
capacity (Peter et. al.., 1972). They are the type I (also is
called slow twitch red intermediate or slow oxidative)
fiber, the type lib (also called fast twitch pale, or fast
glycolytic) fiber, and the type Ila (also called fast twitch
red, or fast oxidative glycolytic) fiber. Both the type I
and type Ila fibers have a high myoglobin content which
accounts for their red color. On the other hand, type Ila
and type lib fibers have rapid rate of contraction and
relaxation, whereas type I fibers are relatively slow in
contracting and relaxing.
The muscle types depend primarily on two different
forms of energy supply. Slow muscles (type I) depend
largely on ATP synthesis associated with mitochondria and an
ample oxygen supply (the oxidative system), whereas fast
muscles (type Ila and lib) depend largely on glycogen and
anaerobic phosphorylation (the glycolytic system). Thus,
the slow fibers have an abundance of mitochondria,
relatively little glycogen, a poorly developed sarcoplasmic
reticulum and the presence of the oxygen carrier myoglobin.
Fast fibers have fewer mitochondria, an abundance of
glycogen and a very well-developed sarcoplasmic reticulum.
The fiber types can be distinguished qualitatively by
histochemical staining for myofibrillar actinomyocin ATPase,
or for enzymes of distinct metabolic functions, such as
anaerobic carbohydrate catabolism or aerobic substrate end
oxidation (Pette et. al.., 1979). By analyzing 10 different
enzymes in individual fibers from human biceps, two clearly
defined fiber types and several subtypes were distinguished
(Lowry et. al.., 1978). They also demonstrated that the
presence among neighboring muscle fibers of a broad spectrum
of highly coordinated enzyme activity.
On the basis of histochemical tests on different enzyme
systems, a fourth category of fiber was also reported (Brook
and Kaiser, 1970; Squire, 1986). It is also fast twitch and
is termed type lie. This type of fiber normally present in
only small numbers in adult human muscles, but they can be
more abundant in young muscle or in pathological cases.
On the other hand, the patterns of myofibrillar
proteins obtained in capillary electrophoresis can be
classified into two types which were correlated to the two
different fiber types (Pette et. a_l., 1979). This
illustrated that the ultrastructural differences between
different histochemically defined fiber types. Comparison
of myofibrillar proteins from fast and slow-twitch skeletal•
muscle showed differences in myosin light chains,
tropomyosin, the inhibitory and tropomyosin-binding
components of troponin, (troponin I and troponin T,
respectively) and a-actinin (John, 1976). Using electron
microscopy it was found that characteristic ultrastructural
variations occur in the M-bands and Z-bands of different
fibers and in other regions, such as myosin heavy and light
chain and of many other proteins (Squire, 1986). This may
form the basis that different types of fibers have different
vulnerability to the damage caused by chemical or other
treatments (Haller, 1985).
The speed of contraction of a muscle as a whole depends
on the proportions of the fiber types of which it is
composed. Type lib fibers are adapted for short term
powerful plastic activity and predominate in flexor muscles,
such as the extensor digitorum longus, and the
gastrocnemius. Type Ila fibers are adapted for sustained
plastic activity and predominate in muscle such as the
diaphragm. Type I fibers are adapted for economical, low
speed, sustained tonic activity. They predominate in deep
extensor muscles muscles, such as the soleus and the cureus,
that are mainly involved in the maintenance of posture
(Bowman, 1980).
For the large difference in many aspects, the different
types of muscle fibers may have quite different response to
the disease state.
1.2.2 Formation and Maintenance of Different Types of Fibers
In the early stages of development, all limbs muscles
are slow-contracting and differentiation into fast or slow
types occurs only in a few weeks. The oxidative system has
been developed in muscles at the late embryonic stage. The
postnatal fiber development produces much more growth in
some fibers than the others, the larger fibers tend to
become less dependent on oxidative enzymes and better
supplied with glycogen and the glycolytic enzymes (type II
fibers). The smaller fibers (type I fibers) remain largely
oxidative (Squire, 1986). This is the origin of different
types of muscle fibers.
Because the development of early muscle fibers into
various well-defined fiber types occurs at a time when motor
nerves are active, it was thought that fiber type
differentiation was due to the nervous input. This idea was
indicated by cross-innervation experiments. Buller e£. al.
(1960) showed that when motor nerves of a fast twitch muscle
and of a slow twitch muscle were cut, exchanged, and then
allowed to re-innervate their new host muscles, the slow
muscle would become faster and the fast muscle would become
slower. Clearly the type of motor nerve serving a muscle
controls in some way the nature of the contractile
machinery.
The nature of the control of motor nerve on the muscle
fiber differentiation was found by Salmons and Sreter
(1976). They showed that the important factor is not
difference in the nerves (a trophic factor) but rather the
pattern of electrical activity they carry. Also, it was
found that in the transformed fibers, the fiber type
specific characteristics such as protein polymorphic
patterns, H-band structure, etc. changes as the
physiological property changes (Squire, 1986). This
suggests that the impulse activity of a motor nerve somehow
modulate gene expression, so that after cross-innervation
some genes are suppressed and others are turned on.
However, cross-innervation did not affect the proportion of
the polymorphic forms of tropomyosin, implying that nerve-
mediated factors are not the only factors involved in
regulating the genes for the proteins of the myofibril
(John, 1976).
On the whole, the action of motor nerves appears to
involve in the initiation and maintenance of the
differentiation of muscle fibers.
1.3 Trophic Interactions Between Nerves and Muscles
When skeletal muscle is deprived of its nerve supply,
it gradually undergoes a series o.f physiological,
biochemical, and morphological changes, which culminate in
atrophy. It is clear that virtually all nerve cells are
involved in similar long-term relationships with other
cells. This is referred as the neurotrophic phenomena. The
definition of neurotrophic phenomena is the long-term
relationships in which nerve cells and target cells interact
so as to influence the structure or function of either
member of the pair (Drachman, 1976).
The neurotrophic phenomena in skeletal muscle can be
roughly classified into three broad categories.
(a) Maintenance of the integrity of muscle.
Denervation cause various changes and atrophy in muscles
while administration of soluble extract of peripheral nerve
significantly ameliorated the atrophy (Davis et. al.., 1988).
The ability of the motor nerve to prevent the denervation
changes is an important aspect of its trophic functions.
(b) Regulation. Regulation of certain metabolic and
physiological properties of muscles takes place in a way
that would adapt them for their appropriate tasks, such as
the initiation and maintenance of the differentiation of
muscle fibers as discussed above.
(c) Formation and maintenance of neuromuscular
junctions. In embryonic development, in cell culture, and
in regeneration, nerve forms connections with skeletal
muscle. Both the initial formation and the subsequent
maintenance of neuromuscular junctions are presumably under
neurotrophic influence (Drachman, 1976; Ishikawa et al.,
1988).
Although the range of neurotrophic effects is large,
the number of possible ways by which the motor nerve can
theoretically transmit trophic instructions to skeletal
muscle is limited. The only possible ways are cholinergic
transmission, release of non-cholinergic trophic substances,
and nerve-muscle interaction.
By using various methods, including neurotoxins
administration to block the activities of the nerve and
disuse, it was found that the trophic control of skeletal
muscle is mediated by more than one kind of neural influence
(Drachman, 1976). Cholinergic transmission plays an
important role in the regulation of many, but not all,
properties of skeletal muscle. Muscle usage is also
important in maintenance of the muscle normality but it
cannot constitute the whole effect of cholinergic
transmission, particularly in the type I fibers (Nemeth
et al.. 1980). It is suggested that neurogenic trophic
substances also exert an effect on one or more of the highly
specialized morphologic, biochemical, or physiological
properties of muscle (Davis e_t ad., 1988). However, the
nature and mechanism of these non-cholinergic trophic
substances are not yet known. The mechanism of 'che trophic
effect of motor nerves on muscles is still largely unknown.
1.4 Energy Metabolism of Skeletal Muscle
1.4.1 Energy Sources of Skeletal Muscle
Muscles convert stored chemical energy into mechanical
energy. The immediate source of energy is the energy-rich
organic phosphate derivatives in muscle while the ultimate
source is the intermediary metabolism of carbohydrates and
1ipids.
The hydrolysis o£ ATP provide directly the energy for
muscle contraction. But there also exists in muscle another
energy-rich phosphate compound, phosphocreatine (CP), that
can supply this energy. When CP is hydrolyzed to creatine
and phosphoric acid, energy will be released. The energy of
ATP is stored in the form of CP by transferring its
phosphate group, together with much of the energy contained
in its chemical bond, to creatine. When needed, CP
transfers its energy back to ADP, forming ATP, which is then
used to provide the energy needed for muscular contraction.
It is believed that this somewhat round about system of
energy transfer renders the muscle cell more resistant to
oxygen deprivation then would be the case if ATP alone were
employed (Solomon and Davis, 1983). Moreover, since CP is
used only to power contraction, other cellular processes
cannot compete directly with contraction for the energy of
CP.
Fatty acids are by far the most important fuel of
resting and sustained exercising muscles, implying aerobic
metabolism in which substrate oxidation by mitochondria is
paramount. During exercise the glycogen store serves as
fuel for glycolysis. Thus the muscle possess large
emergency stores of food in the form of glycogen. As
exercise continues, an increasing amount of blood glucose is
taken up. Type lib fibers play little part in resting
muscle metabolism, but are increasing recruited as the
demand for power increases. Presumably the type Ila fibers
also play a greater role in sustained exercise (Ellis,
1978). Since type lib fibers process only anaerobic
glycolysis, the end waste product is lactic acid, the fast
twitch muscle has a large amount of lactate dehydrogenase
(LDH) which enables the continuous running of anaerobic
glycolysis.
1.4.2 Energy Metabolism in Myopathy States
Energy metabolizing enzyme activities were found to be
altered in various types of myopathies. Such change in
activities may serve as an indicator of the pathological
damage to the muscle.
In dystrophic mouse gastrocnemius most of the NADP-
requiring dehydrogenases increase while NAD-requiring
enzymes decrease or unchanged. The most marked increases
were found in the pentose shunt enzymes, glucose-6-P
dehydrogenase and 6-P-gluconlc dehydrogenase. The most
marked decreases were found in the glycolytic enzymes,
glycerol phosphate dehydrogenase and LDH. The activities of
individual enzyme suggested the overall decrease in
glycolysis. Regarding carbohydrate metabolism, the pattern
of enzyme activity changes suggested a shift from normal
glycolytic and oxidative pathways to the pentose phosphate
shunt (McCaman, 1963). This suggested that selective loss
of the more highly-specialized type II' fibers was
occurring. However, there are two exceptions to this simple
interpretation, namely, the increased activities of
hexokinase and isocitrate dehydrogenase. On the other hand,
many mitochondrial enzyme activities remained at normal
levels until the disease is well advanced (McCaman, 1963).
Also, the change of metabolic substrate levels suggested
increased lipogenesis via extra-mitochondrial citrate
cleavage and esteri£ication of glycerol phosphate (Ellis,
1978).
By the change in LDH and creatine kinase isozyme
patterns, it was postulated that muscular dystrophy disease
in general conferred a metabolic pattern in which mature
forms of enzymes disappeared and immature forms replaced
them (Reichmann and Pette, 1984; Ellis, 1978). Both the
shift in metabolism and the pattern of isozymes reflected
the occurrence of de-differentiation. However, distinct
differences concerning mainly the mitochondrial enzymes and
hexose kinase in immature and dystrophic muscles had been
established and thus implying that dystrophic muscle does
not simply fail to mature but rather that its development is
overlain by the malignant effects of disease (Ellis, 1978).
In denervated muscles, enzymes involved in anaerobic
glycolysis, citric acid cycle, and 3-oxidation of fatty
acids showed increase activities in both types of muscles
(Simard, 1985). The marked reduction in anaerobic
activities in type II fibers (Shackelford and Lebherz, 1981)
and the increase of fetal type isozyme of CK in denervated
muscle (Matsushita§£, 1987) suggested that denervation
results in a partial de-differentiation of muscle fibers
and the trophic effect of nerve on muscle differentiation.
Also, increase activities of hexokinase as found in
dystrophy was also reported in slow muscles (Simard, 1985).
By the similarity of the energy metabolizing enzyme
pattern in denervated and dystrophic muscles, it seems that
the enzyme changes may represent similar secondary effects
caused by different agents (McCaman, 1963) or the
involvement of motor nerve in dystrophy. However, the
nature of these changes in the myopathies is still not
clear.
1.5 Protein Turnover and Proteinases in Skeletal Muscle
1.5.1 Protein Turnover
Most cellular proteins are in a dynamic state of
constant turnover. Here, protein turnover or protein
degradation refers to the hydrolysis of intracellular
proteins to their component amino acids (Goldberg and
St.John, 1976). This process is involved in basic cellular
functions, since the levels of intracellular proteins are
determined both by the rates of synthesis and the rates of
degradation. An additional role of protein breakdown
appears to be the provision of amino acids in times of need,
since overall rates of protein degradation are greatly
accelerated under conditions of nutritional or hormonal
deprivation. Another important function is the disposal of
defective proteins: abnormal proteins produced by specific
mutations or by various experimental manipulations are
selectively recognized and rapidly degraded (Goldberg and
Dice, 1974; Hershko and Ciechanover, 1982).
The proteins of muscle, in common with other tissues,
undergo constant degradation and replacement (Goldberg,
1969a; Pennington, 1977). Changes in the rate of protein
breakdown may contribute to normal muscle growth in the
work-induced hypertrophy (Goldberg, 1969a) and the atrophy
resulting from denervation (Goldberg, 1969b; Goldspink,
1976), dystrophy (Katunuma and Noda, 1982), vitamin E-
deficiency (Dayton et al.. 1979) and cortisone treatment
(Goldberg, 1969b). We know a lot about the factors
influencing protein degradation but a little about their
mechanisms (Libby and Goidberg, 1980). The biochemical
basis for the failure to regulate protein catabolism in
these pathological states is not known. Further studies in
this area may clarify the intracellular mechanism for
protein degradation, and may even lead to improved
therapeutic procedures (Goldberg et. §JL., 1982).
Muscle contains many proteinases, both lysosomal md
non-lysosomal, that could degrade cell protein in. x ivo
(Pennington, 1977). However, in muscles the role of any
given proteinase or organelle in the breakdown of average
cell protein is unknown (Libby and Goldberg, 1980).
1.5.2 Proteolytic System
The systems or organelles of the cell that are
responsible for the degradation of cellular proteins must
contain endoproteolytic and exoproteolytic activities but
may also contain other enzymatic activities to achieve the
end point, namely complete hydrolysis. An obvious locus for
degradative process is the lysosome with its high
concentration of hydrolases (including proteinases, usually
referred to as cathepsins). However, the nonlysosomal
proteinases are also responsible for degradation of cellular
proteins (Beynon and Bond, 1986).
Proteolytic enzymes are classified mechanistically
according to the functional residues at their active sites:
serine, cysteine, aspartic, or metalloproteinase (Barrett,
1977). In general, the lysosomal proteinases are of the
cysteine and aspartic class, cytosolic proteinases are of
the cysteine class and membrane-bound proteinases are often
metallo- or serine proteinases. Proteinases that act
extracellularly are generally serine proteinases (trysin,
blood proteinase), but metalloproteinases (collagenases) and
aspartic proteinases (pepsin) also function outside of cells
(Beynon and Bond, 1986).
1.5.2.1 Lysosomal Proteinase
The lysosomal system is well suited for a major role in
endogenous proteolysis because it is able to sequester
cellular material by the process of autophagy and has
immense proteolytic capacity (Dean and. Barrett, 1976).
Lysosomes of most tissues contain at least four well-defined
endopeptidase (cathepsin B, cathepsin D, cathepsin H and
cathepsin L), one exopeptidase (cathepsin C, a dipeptidyl
amlnopeptidase), and several peptidase (e.g. cathepsin A).
Also, a process of autophagic engulfment of cellular
constitutes has been observed under a variety of
pathological or physiological conditions (Hershko and
Ciechanover, 1982).It is generally accepted that lysosomes
are responsible for hydrolyzing pinocytized and phagocytized
proteins (Goldberg and St.John, 1976; Katunuma and Noda,
1982).
Role of lysosomes in protein degradation has been
investigated extensively. Degradation of most short-lived
proteins or abnormal proteins is probably nonlysosomal in
nature. (Neff ejt al., 1979). For degradation of long-lived
proteins, most or all of enhanced protein breakdown in
mammalian cells is carried out by the lysosomal system, but
there are conflicting reports concerning the involvement of
the lysosomal pathway in the basal degradation of these
proteins. It is possible that the proportion of lysosomal
pathway is greater in non-growing tissues, such as the
normal liver or muscle (Hershko and Ciechanover, 1982) and
in cells where proteolysis is accelerated (Neff et al..
1979).
It has been suggested that lysosomal proteinases
contribute to the degradation of myofibrillar proteins.
Cathepsins B, H and L are thiol proteinases and cathepsin D
is a aspartic proteinase in lysosome. They all have optimum
activities at acidic environment. The degradation of
purified myofibrillar proteins by cathepsins B and D was
clearly demonstrated by sodium dodecyl sulfatepoly
acrylamide-gel electrophoresis by Schwartz and Bird (1977).
The ability of cathepsins to degrade various myofibrillar
components is also investigated. Cathepsin B can degrade
some myofibrillar proteins, such as myosin, troponin and
tropomyosin. Cathepsin H cannot degrade any native
myofibrillar proteins except troponin T (Katunuma and Noda,
1982). Also, it was found that cathepsin D degraded the Z-
line and filaments adjacent to the H-zone some myofibrillar
proteins, such as myosin, troponin, tropomyosin. Cathepsin
L causes the fragmentation of myofibrils, and degraded the
Z-line and M-line (Matsukura et. al.., 1984). Cathepsin L is
the most important endopeptidase among the lysosomal thiol
proteinases for its high proteolytic activity and its
ability to disassemble the myofibrils.
The exact role of lysosomal proteinase in muscle is not
clear. Cathepsin activities were found to be elevated in
muscle wasting conditions, such as denervation (Maskrey
et al.. 1977), toxin-induced muscle paralysis (TAgerud
et al., 1986), and Duchenne muscular dystrophy (DMD)
(Katunuma and Noda, 1982). Also, enhanced protein breakdown
was shown in muscles lacking in nutrients and in insulin
through a lysosomal process (Furuno and Goldberg, 1986).
Cathepsin L was also supposed to be responsible in the
postmorten aging of muscle (Matsukura et. al.., 1984). Thus,
the role of lysosomal proteinases in wasting muscles is
rather confirmed. On the other hand, it has been reported
that the reaction products of cathepsin B and D was found in
two types of lysosomes in muscle cells (Bird et al..
1980). This shows the involvement of these enzymes in the
protein degradation o£ muscle cells. However, Libby and
Goldberg (1981) suggested that although the lysosome is the
primary site for the acetylcholine receptor degradation and
perhaps for degradation of other surface proteins, the
breakdown of most proteins in myotubes seems to involve a
distinct proteolytic system requiring metabolic energy. So,
the role of lysosome in protein degradation in normal cell
is not clear.
1.5.2.2 Calpains and Other Cytosolic Proteinases
Cytosolic proteinases have been isolated and
characterized from many cell types in the last 10 years. It
is now clear that significant proteolysis takes place in the
cytosolic compartment of cells and that this is important in
the activation, posttranslational processing, and initiation
of extensive degradation of proteins (Beynon and Bond,
1986). The proteinases that have been isolated from the
cytosol of various cells are cysteine proteinases, and many
have requirements for activation ligands, e.g., Ca2+ for the
calpains, ATP for the ATP-dependent proteinases (Beynon and
Bond, 1986).
Proteinases having a neutral pH optimum and an absolute
requirement for calcium ions are found in virtually all
mammalian cells (Mellgren, 1987). They are known as
calpains (CALcium-dependent paPAIN-like proteinases). They
are also known as calcium-activated neutral proteases
(CANP), calcium-activated factor (CAF), kinase-activating
factor (KAF), receptor-transforming factor (Enzyme Committee
of the International Union of Biochemistry, 1981). Two
homogenous isozymes with different Ca2+-sensitivities exist:
calpain I and calpain II, active at )iM or mM concentration
of Ca2+, respectively (Wheelock, 1982). It has been
presumed to participate in various cellular functions
mediated by Ca2+, but their precise functions are not clear.
They may be part of the general protein catabolic pathway in
the cells. On the other hand, Mellgren (1987) has proposed
that they may involve in the process of cell membrane
fusion, the calcium-dependent proteolysis in postsynaptic
membrane modeling in the hippocampus after long-term
potentiation, arid the activation of membrane-associated
protein kinase C.
Busch et, §2- (1972) reported the isolation of a protein
from skeletal muscle that causes Z-line removal from
myofibrils in the present of Ca2+ at pH 7.0. Calpain has
been purified from chicken, rabbit, porcine t and human
(Dayton et. al.., 1976a; Dayton §2 al.., 1981; Imahori, 1982;
Kawashima et. al.., 1984). The purified enzyme showed
activities in removal of the Z-lines, partial degradation of
the M-line, degradation of troponin, tropomyosin, and C-
protein but no effect on myosin, actin, or a-actinin (Dayton
e£ si., 1976b). This suggested that calpain may be
responsible for myofibrillar protein degradation which must
involve disassembly and proteolysis of the insoluble
myofibrillar array at physiological pH. Both calpain I and
calpain II were identified in (Wheelock, 1982) and purified
from (Dayton et al.. 1981; Otsuka et §1., 1988) skeletal
muscle. Evidence shows that calpain I is the active form in
skeletal muscle (Dayton et. gQ.., 1981; otsuka et. §1-, 1988).
In isolated skeletal muscles, protein breakdown can be
stimulated by treatments that increase intracellular Ca2+
(Baracos el al., 1986). By using different classes of
proteinase inhibitors, it was concluded that this effect is
caused by the activation of a proteolytic pathway involving
nonlysosomal thiol prote inase (s) (Ishiura ai al-,. 1982;
Zeman £i §1.., 1985; Baracos et al.., 1986; Furuno and
Goldberg, 1986). Up to now, the only Ca2+-dependent,
cytosolic thiol protease known is calpain. It is quite
possible that calpain is responsible for protein degradation
in some pathological states in which the intracellular Ca2+
level is elevated through the damaged sarcolemma or the
damaged sarcoplasmic reticulum because it was proposed that
Ca2+ overload provides a general mechanism for cell necrosis
in muscle disease (Joffe el al.., 1981).
The theory of the involvement of calpain in
myofibrillar protein degradation is supported by various
reports. Calpain activity was found to be increased in
muscle taken from human possessing Duchenne muscular
dystrophy (Kar and Pearson, 1976), in the atrophying
skeletal muscle of vitamin-E-deficient rabbits (Dayton
Si al., 1979), in denervated skeletal muscles (Elce ei al..
1983) and in the tenotomized muscle of rat (Baker and
Margolis, 1987). On the other hand, the electromicrographs
In several cases o£ diseased muscle of Duchenne muscular
dystrophy, ischemia, and prune berry syndrome show intact M-
line and suggesting that calpain but not the lysosomal
proteinases is involved in the degradation process because
only calpain degrade myofibrils at the Z-line without
removing the M-line (Otsuka et al., 1988). However,
essentially normal levels of calpain was found in patients
with limb-gridle dystrophy and certain denervating diseases
(Bird ejL aJL.., 1980). It is not clear whether the elevation
of intracellular Ca2+ level or the increase of calpain
activity is responsible for the protein degradation in these
disease states.
By using different proteinase inhibitors, it was
illustrated that the basal degradative process in muscle did
not involve lysosomal or thiol proteinases (Furuno and
Goldberg, 1986).
By the finding that breakdown of average protein
decreases in the presence of 2-deoxyglucose, an inhibitor of
glycolysis or of azide, an inhibitor of oxidative
phosphorylation, it is proposed that the breakdown of most
proteins in myotubes seems to involve a proteolytic system
requiring metabolic energy (Libby and Goldberg, 1981).
In reticulocytes, a ubiquitin-dependent, ATP-dependent
proteolytic system has been described. (Hershko and
Ciechanover, 1982). An alkaline ATP-dependent protease that
does not require ubiquitin has been described in soluble
liver extracts (Beynon and Bond, 1986). But it is unlikely
that these systems are involved in muscles.
Moreover, it is now known that a ATP-dependent
degradative system is present in all mammalian cells
(Goldberg et. al., 1982). A large ATP-dependent proteinase
has been described in muscle cells, but the properties o£
this enzyme is not yet clear (Beynon and Bond, 1986).
A high-molecular-mass proteinase possessed three
different hydrolytic activities termed multicatalytic
proteinase was isolated from rat skeletal muscle (Dahlmann
sLl- 1985a). Fatty acids in the physiological
concentrations activate this enzyme (Dahlmann et. al.,
1985b). It is suggested that, in. vivo, potential activators
such as fatty acids can induce the multicatalytic proteinase
to participate in muscle protein breakdown. But it was
reported that the amount and activity of muscle
multicatalytic proteinase are not affected by starvation-
induced hyperlipacidaemia (Dahlmann et al., 1987). Thus,
the role of this enzyme is not yet clear.
Hydrolase H, a thiol enzyme exhibiting
aminoendopeptidase activity and optimum pH at 7.5 to 8.0
(Okitani et. §X., 1981), and a heat-stable alkaline thiol
proteinase exhibiting optimum pH at 8.0 at.60°C (Makinodan
ai al-- 1988) were also described in skeletal muscle. But
there is still not enough information to evaluate their role
in muscle protein turnover.
1.5.2.3 Other Proteinases
In the past 30 years there have been a number of
chymotrysin-1ike proteinases reported to be active in muscle
homogenates at alkaline pH. Due to their optimum activity
at alkaline pH, the proteinases are generally been referred
to as alkaline proteinases. Most of these enzymes are
found to be serine proteinases (Bird et. ai.., 1980).
It was found that alkaline proteinases were not
localized in true muscle cells but in mast cells and did not
contribute significantly to breakdown of average proteins in
muscle (Libby and Goldberg, 1980). On the other hand, it
was reported that purified serine proteinase actively
degrades native myosin, actin, troponin, tropomyosin, a-
actinin and M-protein from rabbit muscle (Yasogawa, 1978).
Also, there are dramatic increases in the mast cell serine
proteinases in muscular dystrophies (Katunuma et. a_l., 1978;
Sanada et. al.., 1978), starvation, and hormone imbalances
(Bird et. al.., 1980). Thus, mast cell serine proteinases may
involve in the accelerated or pathological degradation of
myofibrillar proteins.
On the whole, we know only a little about the
proteinases involved in the basal protein turnover. For the
enhanced protein turnover in pathological states, we have
identified some responsible candidates. However, their
mechanism is still not clear.
1.6 Free Radicals and Their Scavenging Enzymes
1.6.1 Free Radicals and Their Damages
1.6.1.1 Free Radicals in Biological System
There are many ways to injure and kill cells. Amongst
these is an important class of reactions dependent on the
production of free radical Intermediates to trigger an
expanding network of multifarious disturbances.
Free radicals can be defined as molecules or molecular
fragments with an unpaired electron (Slater, 1984). They
are usually highly reactive and thus may cause tissue damage
(Machlin and Bendich, 1987).
Intracellular free radicals are generated from the
autoxldation and consequent inactivation of small molecules
such as reduced flavins and thiols, and from the activity of
certain oxidases, cyclooxygenases, lipooxygenases,
dehydrogenases, and peroxidases. Oxidases and electron
transport systems are the prime and continuous sources of
intracellular reactive oxygenated free radicals (Fridovich,
1976; Machlin and Bendich, 1987). Electron transfer from
transition metals such as iron to oxygen-containing
molecules can also initiate free radical reactions. The
sites of free radical generation encompass all cellular
constituents including mitochondria, lysosomes, peroxisomes,
and nuclear, endoplasmic reticula, and plasma membranes as
well as sites within the cytosol (Machlin and Bendich,
1987).
Molecular species produced include, but by no means are
limited to, hydroxyl, peroxy, hypochlorite, superoxide, and
alkoxy radicals, and reactive molecules such as hydrogen
peroxide and singlet oxygen, which are not free radicals but.
are certainly reactive and capable of causing damage
(Machlin and Bendich, 1987).
In almost all aerobic cells, the oxygen free-radicals
are formed and they are mainly the source of intracellular
free radicals (Halliwell and Gutteridge, 1984). They are
the superoxide anion radical hydrogen peroxide
(H2O2), and the hydroxyl radical (OH).
02~ is made during biological oxygen reduction, but
the major biological sources remain unidentified. However,
a large number of flavoprotein hydroxylases, oxidases and
dehydrogenases can produce substantial amounts of 02~
(Fridovich, 1976). In the mitochondrial respiratory chain,
02~ is generated at two sites: the NADH dehydrogenase and
the ubiquinone-cytochrome b area. Therefore 02~ may be
produced as a by-product of oxidative metabolism,
particularly in the abnormal state. It was proposed that
the ubiquitous mitochondrial membranes is the most important
Physiological source of 02~ in animal cells (Turrens and
Boveris, 1980). O2~ may cause the depolymerization of acid
Polysaccharides (Fridovich, 1976). However, O2 itself
3oes not appear to be directly cytotoxic but is able to
initiate radical chain reactions (Halliwell and Gutteridge,
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Reaction (2) is referred to be Haber-Weiss reaction.
But the rate constant for the reaction in aqueous solution
is virtually zero. This reaction can only happen by the
catalysis of transition metal ions. Reaction (5) is called
the Fenton reaction. The combination of reaction (3) and
(5) is an iron-catalyzed Haber-Weiss reaction and the net
result is shown as reaction (6).
By the chain reaction induced by 02'~, H202 and OH- are
produced. Both of them are quite toxic to the cell. On the
other hand, H202 alone can also produce OH- through the
combination of reaction (4) ,(5) and (2) in the presence of
iron salt. The net result are shown as reaction (7). In
reaction (6) and (7), other transition metal ions, such as
copper ion, may replace iron ion as the catalyst.
H202 is the most stable intermediate of the reduction
of oxygen. It can be generated directly by divalent
reduction of 02 or indirectly by the univalent reduction of
°2 followed by dismutation of 02-~. H202 is the primary
Product of the reduction of 02 by numerous oxidases, such as
urate oxidase (Halliwell and Gutteridge, 1984). Its
production has been demonstrated in suspensions of
microsomes (membranes of the endoplasmic reticulum),
Illuminated chloroplasts, mitochondrial membrane, tissue
homogenates, liver slices, and in whole perfused rat liver
(Fridovich, 1976).It can also be produced by the peroxisomes
(microbodies), cytosolic enzymes and the nucleus (Chance
aJL-, 1979). The major sources of intracellular may
be endoplasmic reticulum and peroxisomes (Fridovich and
Freeman, 1986).
It is believed that Yl2°2 ls toxic, but it is not clear
why it is so. H2O2 can cause the oxidation of sulfhydryl
compound and of the methionyl residues in proteins. It can
also cause the peroxidation of polyunsaturated fatty acids.
However, these oxidations proceed at reasonable rates only
at concentrations of H2O2 which exceed those attainable in
by at least four orders of magnitude. It seems
possible that H2O2 is damaging, not by virtue of direct
attack upon cellular components, but rather because it can,
by reaction with C ,i.e., through reaction (6), or with
Fe2+ i.e., through reaction (7), giving rise to the
etremely reactive hydroxyl radical (Fridovich, 1976).
Hydroxyl radical ('OH) is the most potent oxidant known
(Fridovich, 1976). It reacts with extremely high rate
c°nstants with almost every type of molecule found in living
cells; sugars, amino acids, phospholipids, DNA bases and
°£ganic acids (Halliwell and Gutteridge, 1984). In the
biological system, it is mainly 02~ and H2O2 that are
Produced directly by the natural pathway. 02~ and H2O2 are
less reactive and can diffuse away from their sites of
formation, leading to OH- generation in different parts of
the cell whenever they meet a spare transition metal ion
(Halliwell and Gutteridge, 1984).
1.6.1.2 Cell Injury Caused by Free Radicals
Reactive free radicals are able to produce chemical
modifications of, and damage to proteins, lipids,
carbohydrates and nucleotides (Slater, 1984). Therefore, if
the reactive free radicals are produced in. vivo. in amounts
sufficient to overcome the normally efficient protective
mechanisms, metabolic and cellular disturbances are expected
to occur in various major ways.
If the reactive free radical is formed close to DNA,
then it may produce a change in the structure resulting in a
mutation or cytotoxicity. Oxidizing free radicals can alter
the redox state of the NAD+NADH and NADP+NADPH couples and
may produce NAD(P)• that can dimerize. Free radicals can
also add to nucleotides to produce significant changes in
their biological properties. Protein and non-protein thiol
groups are readily oxidized by many free radicals and thiol
radicals (S-) produced may dimerize and this type of free-
radical-mediated disturbances of thiol groups may lead to
profound changes in enzyme activity. Free radicals can also
interact with cell components such as protein, lipid and
nucleic acid, to form a stable covalently bound adduct that
may grossly distort structure and function (Slater, 1984).
1.6.2 Protection Against Free Radicals
1.6.2.1 The Protection Mechanism
Since oxygen free radicals are the species which are
Usually involved in the cells, protections are mainly
concentrated on these species. Defenses against free
radical damage include a-tocopherol (vitamin E), ascorbic
ucid (vitamin C), 3-carotene, glutathione (GSH), uric acid,
bilirubin, and several metalloenzymes including glutathione
Peroxidase (GSH-peroxidase) (selenium), catalase (iron), and
Reactive free radicals may also damage cells by
membrane damage. They can covalently bind to membrane
enzymes andor receptors, thereby modifying the activities
of membrane components. They can also covalently bind to
membrane components and change their structure and produce
effects on membrane function andor antigenic character.
Free radicals can also initiate of lipid peroxidation of
polyunsaturated fatty acids (PUFA). In lipid peroxidation a
primary reactive free radical interacts with a PUFA to
initiate a complex series of reactions that result in a
variety of degradation products: diene-bonded PUFA free
radical, lipid hydroperoxide, ethane, pentane, malonaldehyde
(MAD), and some fluorescent and chemiluminescence materials.
As a result, lipid peroxidation produce direct effects on
membrane structure, and associated influences of the
products of peroxidation on membrane fluidity, cross-
linking, structure and function (Slater, 1984). Extensive
lipid peroxidation can result in membrane disorganization.
superoxide dismutase (SOD) (copper, zinc, manganese) and
protein such as ceruloplasmin (copper) (Machlin and Bendich,
1987).
Only three essential nutrients can directly scavenge
free radicals. Vitamin E (a-tocopherol) is the major lipid-
soluble antioxidant present in all cellular membranes and
protects against lipid peroxidation. It can act directly
with a variety of oxy radicals, including the peroxy radical
(ROO•), CCI3•, as well as with the superoxide radical• (O2•~)
(Machlin and Bendich, 1987). Vitamin E interrupts the chain
reaction by reacting rapidly with the chain-propagating
fatty acid radicals to yield a-tocopherol radical, which is
unable to further propagate the chain reaction. It is
particularly effective in this regard because it is an
excellent antioxidant and because its hydrophobic properties
cause it to partition into the biological membranes
(Fridovich and Freeman, 1986).
Vitamin C is water soluble and, along with vitamin E
can quench free radicals as well as singlet oxygen.
Ascorbic acid has been shown to react directly with
superoxide, hydroxyl radicals, and singlet oxygen. Ascorbic
acid can also regenerate the reduced, antioxidant form of
vitamin E (Machlin and Bendich, 1987).
3-carotene, a pigment found in all plants, is the most
efficient quencher of singlet oxygen known in nature and can
also function as an antioxidant. It has been found in
cellular membranes,including those of lysosomes (Machlin and
Bendich, 1987).
There are, In addition, several nutritionally essential
minerals incorporated into protective antioxidant enzymes.
Zinc, copper, and manganese are required for the activity of
the two types of SODs. Selenium is an essential component
of GSH-peroxidase. Iron involves in the activity of
catalase, a hemoprotein. GSH Is a tripeptide composed of
nonessential amino acids and involved in the function of
GSH-peroxidase (Machlin and Bendich, 1987).
The antioxidant enzymes function mainly intra-
cellularly. Therefore, extracellular free radicals must be
inactivated by the circulating antioxidants such as vitamins
discussed as well as by ceruloplasmin, a copper-containing
Protein (Machlin and Bendich, 1987).
In skeletal muscles, Boldyrev et a..( 1988b) suggested
that histidine-containing dipeptides, carnosine ()3-alanyl-L-
histidine) and its methyl derivatives, anserine, play the
antioxidative role. They believed that skeletal muscle
dipeptides are involved in the regeneration of the active
form of a-tocopherol and serve as an effective antioxidant
buffer which protects muscle cell membranes from
uncontrolled lipid peroxidation. They proposed that
skeletal muscle used these dipeptides rather than
Glutathione because that NADPH was needed for the reduction
glutathione disulfide (GSSG) to GSH and muscle lacked of
NADPH-regenerating enzymes (Boldyrev et al1988a).
1.6.2.2 Free Radical Scavenging Enzymes
The primary defense in the cell against free radical
damage is provided by enzymes that catalytically scavenge
the intermediates of oxygen reduction. There are cytochrome
oxidase, SOD with either iron (FeSOD) or manganese (MnSOD)
at the active site, and others with both copper and zinc
(CuZnSOD). FeSODs and MnSODs are characteristic of
prokaryotes, while CuZnSODs are characteristic of
eukaryotes. Eukaryotes generally contain both CuZnSOD and
MnSOD. There are also catalases that are hemoproteins, and
others, found in organisms incapable of heme synthesis, that
way be flavoproteins. There are heme-containing peroxidases
•«
that can utilize' a wide variety of electron donors for the
reduction of H2O2, and others that contain selenium and
specially utilize reduced GSH as the reducing substrate
(Fridovich, 1978).
The first line of defense is simply avoidance of the
univalent pathway by enzymes with multiple electron-carrying
components, which can accomplish the tetravalent reduction
of dioxygen to water without the release of intermediates.
Cytochrome oxidase is such an enzyme, and in actively
respiring cells such as lung cell, it accounts for more than
50% of the observed dioxygen reduction without releasing
°2'~ or H2O2 as intermediates. This strategy of avoidance
of the univalent pathway reduces the burden of reactive
intermediates the cell must face (Fridovich and Freeman,
1986).
The second line of defense is provided by SOD. 02~ is
cleared by SOD through the dismutatlon reaction. SODs
catalyze the reaction
and do so with an efficiency that approaches the theoretical
diffusion limit (Fridovich and Freeman, 1986).
Catalase removes H2O2 by converting it to water and
oxygen
and functions as the third layer of antioxidant defense.
Indeed, catalase can act as a peroxidase when the
concentration of H2O2 is kept low and electron donors such
as alcohols or formate are present (Oshino et. al.., 1973;
Fridovich, 1976). GSH-peroxidase, as well as other
peroxidases, decomposes H2O2 and lipid peroxides. It is
thought to play a major role as scavengers of H2O2 under low
endogenous production rates of H2O2 pertaining under
Physiological conditions contributed by the generation
within endoplasmic reticulum (Jones et. al.., 1981). The
relative contributions of catalase and GSH-peroxidase in
decomposition of endogenously generated H2O2 are determined
largely by the subcellular localizations of the enzymes in
the cells (discussed later) and the lower Km of GSH-
Peroxidase for H2O2 (Jones e_t al., 1981). However, catalase
becomes more important because the catalytic reaction, which
3- 6.3 Involvement of Free Radicals in Various Diseases
Free radical pathology is the result of uncontrolled or
abnormal radical reactions occurring in the cells.• The
sxtent of tissue damage is the result of the balance between
bbe free radicals generated and the antioxidant protective
has a greater rate constant, predominates over the
peroxidation reaction (Fridovich and Freeman, 1986).
Glutathione-reductase GSSG-reductase), which catalyzes the
reduction of the GSSG by NADPH nd prevents depletion of
cellular glutathione thiol, is also thought to be involved
in these processes (Fridovich and Freeman, 1986).
It is clear that efficient removal of the first two
intermediates of oxygen reduction, C2~ and H2O2 will
prevent formation of the third, OH-. All these enzymes
remove 02~ and H2O2 in the cell. This is fairly rational,
since OH reacts avidly with many substances and its
specific enzymatic scavenging would be Impossible
(Fridovich, 1978)'.
These enzymes have different locations in the cell.
CuZnSOD is found predominantly in cytosol, while MnSOD is
found mainly in mitochondria (Asayama et. al.. 1986). GSH-
Peroxidase is a cytosolic enzyme (Jones gl al.., 1981). In
Hiany cases, catalase is localized in subcellular .organelles
such as the peroxisomes (microbodies) of liver and kidney or
in much smaller aggregates, such as the microperoxisomes
found in a variety of other cells (stauber and Bird, 1974;
Chance et. al., 1979).
defense system.
Some diseases are suggested to be related to free
radicals. Continuous exposure to free radical-containing
environmental pollutants has been associated. with lung
damage, emphysema, and cancer (Fridovich and Freeman, 1986).
Colon cancer, precancerous dysplasias of the cervix and
intestine are also found to be related to the free radicals.
Cardiovascular diseases including atherosclerosis and the
tissue injury after myocardial infraction have been shown to
result in part from free radicals generated at the site of
damage. In addition, the formation of cataracts, the
photodermatoses, inflammatory diseases including arthritis,
and the aging process itself have all been associated with
free radical damage (Machlin and Bendich, 1987).
1.6.4 Involvement of Free Radicals and Their Scavenging
Enzvmes in Skeletal Muscle and MvoDathy
Considerable quantities of peroxides were measured in
many tissues, including skeletal muscles, with the depletion
°f vitamin E (Bieri and Anderson, 1960). This showed that
free radicals can be formed in muscle. Muscle tissue free
radicals originate primarily in mitochondria. They are
delated to flavoprotein and ubiquinone-semiquinone radicals
(Nagaoka §JL., 1981). The free radical concentration in
muscle was shown to be associated with the rate of electron
flow in the respiratory chain, which is regulated by. the
mitochondrial metabolic states (Koren§£. al.., 1983). As a
tesult, the concentration of free radical is greatly
Increased by exercise and thus may cause limited damage to
mitochondrial membranes which, in a chronic training
situation, may be the initiating stimulus to mitochondrial
biogenesis (Davies, 1982).
Lipid peroxidation is known to be increased in
nutritionally induced animal myopathies (Bieri and Anderson,
I960). The lipid peroxides, measured as thiobarbituric
acid-reactive products, were reported to increase in muscles
of chicken, mice (Omaye and Tappel, 1975) and human (Kar and
Pearson, 1979) with muscular dystrophies. Lipid
peroxidation of the red blood cells was found to be
significantly higher in Duchenne muscular dystrophy patients
(Matkovics et a_l., 1982).
For the free radical scavenging enzymes, their
activities has been investigated in many forms of
myopathies. Kar and Pearson (1979) reported elevated levels
of catalase and GSSG-reductase activities in human muscular
dystrophies. In animal dystrophies, Omaye and Tappel (1975)
deported increased activities of GSH-peroxidase and GSSG-
eductase in dystrophic chickens and mice. Park et al.
(1979) reported Increases in activities of GSH-peroxidase,
GSSG-reductase and SOD in avian muscular dystrophy. All of
these findings suggest increased turnover of oxygen species
in these muscular dystrophies. Mizuno (1984) found
increased activities in SOD in early stage of the
development and suggested the presence of increased turnover
°f active oxygen species from the early stage of the disease
in avian muscular dystrophy and the involvement o£ oxygen
species in pathogenesis o£ this disorder.
In denervated rat muscles, Asayama et §2.. (1986) found
that the CuZnSOD activity decrease slightly in the slow but
not in £ast muscle. Also, activities of MnSOD, cytochrome c
oxidase, GSH-peroxidase decrease only in the slow muscle.
From these result, free radicals do not seems to involve in
pathogenesis of denervation myopathy.
By a systematic study of free radical scavenging
enzymes in neuromuscular disease, Burr et. al.. (1987) showed
that muscles involving in motor neuron disease demonstrated
markedly decrease MnSOD concentrations and increase GSH-
peroxidase activity with normal CuZnSOD activity. The
result of SOD is similar to that of Asayama e£ aJL.. (1986)
but that of GSH-peroxidase is just opposite. In muscle of
primary polymyositis patients, CuZnSOD, GSH-peroxidase and
catalase activities decrease markedly. For myotonic
dystrophy patients, their muscles exhibit no change from the
control muscle in these enzymes. These studies indicate
disease-specific differences from the normal in redox-active
enzymes in DMD and other neuromuscular disorders. This
raises questions regarding the control of redox metabolism
in muscle, but does not permit formation of a definitive
hypothesis regarding pathogenesis (Burr gt.!.., 1987).
The contribution of free radicals and the related
enzymes in myopathy is not yet clear. By the above result,
it seems that in those involved in the failure of motor
neuron, the oxygen species do not actively participate in
the pathogenesis. However, Stauber e_t aJL. (1977)
demonstrated elevated catalase activities in denervation or
muscle wasting caused by other factors and suggested that
the specific activities of catalase in muscle homogenates
may be a valid indicator of the presence of skeletal muscle
wasting. This shows the possible ubiquitous involvement of
catalase in myopathy. Also, high specific activities of
catalase are found in tissues that readily oxidize lipids,
such as red muscles. Therefore, the role of catalase in
skeletal muscle is waiting to be clarified.
17 Altered Physiblogical States of Skeletal Muscle
One of the reasons for studying muscle is to look into
the sometimes-fatal neuromuscular diseases that occur in
human.
Apart from the well-known temporary disorders in muscle
such as cramp, stitches, and general, sometimes painful
muscular fatigue associated with lactic acid accumulation,
various distinct categories of long-term muscular or
neuromuscular disorders have been identified.
Two broad divisions occur in the description of
Myopathies. One division includes the dystrophies that are
inherited, and the other includes the defects acquired after
birth.
Inherited myopathies include the classic muscular
dystrophies such as Duchenne dystrophy, Becker muscular
dystrophy, congenital muscular dystrophy, limb-gridle
dystrophy, myotonic dystrophy and biochemical disorders such
as glycogen storage diseasse and lipid storage diseases.
Also in this category are the diseases clearly associated
with motor neuron defects such as the spinal muscular
atrophies.
Acquired myopathies include three broad types:
inflammatory, noninflammatory, and traumatic myopathies.
Inflammatory myopathies can either be idiopathic in origin
or due to infection from extrinsic agents (viruses,
bacteria, parasites). The idiopathies include polymyositis
and sarcoidosis. Extrinsic inflammatory myopathies include
the problems associated with viruses such as the influenza
virus.
Noninflammatory acquired myopathies can arise from a
host of idiopathic problems, such as endocrine disease
(thyrotoxic myopathy) and carcinomatous myopathy. But they
can also arise from extrinsic sources, such as drugs or
alcohol. The over-reactivity syndromes such as cramp,
tetany, contracture, etc. are also included in this
category. There are also two bacterial toxin caused non¬
inflammatory myopathies, botulism and tetanus.
A special example of acquired myopathy is the disorder
due to physical damage or trauma. The well-known disease
myasthenia gravis is classified as a disease of the
neuromuscular junction (Squire, 1986).
In many forms of myopathies, it is not known whether
the very obvious structural or biochemical abnormalities in
the muscle are the primary defect or whether these are
symptoms or consequences of a defect elsewhere in the same
motor unit. The studies of denervation model may provide a
clue to this problem. Also, the studies of systems which
may be involved in cell damage or cell component
degradations would provide an insight into the pathogenic
mechanism.
1.8 Objectives of the Present Study
In this study, enzyme activities in two models of
myopathy were investigated. They are muscle atrophy caused
by alcohol administration and that resulted from
denervation. The enzymes examined belongs to mainly three
systems. They are energy metabolizing enzymes, lysosomal
enzymes and free radical scavenging enzymes. The objective
of this study is to characterize the biochemical events
during muscle atrophy following ethanol administration and
surgical denervation. During the denervation atrophy
studies, the effect of clenbuterol was also investigated to
see whether the denervation induced muscle atrophy could be
reversed by 3-agonist administration. If muscle atrophy can
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The chemicals used and their suppliers are listed in
Table 2-1. All chemicals are of analytic grade.
2.2 Animals
Sprague-Dawley rats originated from Charles River
Laboratory (Japan), born and raised in our animal care unit,
were used. All animals were housed in wire-bottomed cages,
acclimated at a room temperature of 22°C with alternate
cycles of 12 hours of light and darkness, and were provided
with Purina rat chow and tap water.
Animal treatment protocol rats will be described in
detail in the corresponding chapters..
2.3 Muscles Used in This Study
The muscles of the rat hind limbs were the targets of
this study. These included gastrocnemius, extensor
tfigitorum longus (EDL), soleus, and tibialis anterior (TA),
Figure 2.1 is an anatomical picture which shows the
arrangement of these muscles in the lower leg of rats.
Gastrocnemius and TA are muscles having type I and
type II fibers (details about these fibers have been
described in chapter 1) in similar amount (Close, 1972) and
are treated as mixed type muscles. EDL contains mainly.type
H fibers (90% type Ila and 10% type I) (Squire, 1986) and
is taken as representative of fast-twitch muscle. Soleus
Figure 2.1 Anatomy of the hind-leg muscle of rat. (From
Greene, E.C.: Anatomy of the rat American
Philosophical Society, 1935)
consists of mainly type I fibers (85% type I and 15%
type Ila) (Squire, 1986) and is treated as a slow-twitch
muscle (Asayama gt, al.., 1986).
EDL and TA are innervated by deep peroneal nerve, while
gastrocnemius and soleus are innervated by tibial nerve
(Greene, 1935). Both deep peroneal (one branch of the
common peroneal nerve) and tibial nerves originate from
sciatic nerve (Bruck-Kan, 1979). Therefore, injury of the
sciatic nerve will have an effect on these muscles.
2.4 Methods
2.4.1 Preparation, of Muscle Homogenate
Rats were killed by decapitation and muscles were
removed. After the muscles had been excised from the
animals, they were kept in ice-cold normal saline until
further processing. The muscles were then blotted dry and
weighed. All connective tissues and nerves were removed
with scissors, and the muscles were minced and homogenized
with a Polytron (3 X 30 sec with 30 sec intervals) in 9
volumes of ice-cold 50 mM Tris (pH 7.4 at 20°C). As a
result, 10% crude homogenates were prepared. The crude
homogenates were then further homogenized in a Teflon-pestle
homogenlzer by five strokes, followed by sonication
(3 x 15 sec with 10 sec intervals). The debris of the crude
homogenate was removed by low speed centrifugation (800 g,
10 minutes). The clear supernatants were used for all the
Assays except for the determination of MAD. All procedure
were done at 4°C. The muscle homogenates were then frozen
quickly In liquid nitrogen and kept at -70c until thawing
for the various assays.
2.4.2 Protein Assays
Protein content of muscle homogenate was determined
using the method modified from that described by Lowry
et al. (1951). The samples were first digested in 1 M NaOH
at room temperature for 20 minutes, then 0.1 ml of digested
protein was added to 1.0 ml of reagent C. After standing at
room temperature for 10 minutes, 0.1 ml of 1 M Folin-
Ciocalteus phendl reagent was added. The absorbance at
750 nm was measured after standing the final mixture at room
temperature for a further 45 minutes. Reagent C was
prepared by mixing 100 ml 2% Na2CC3 in 0.1 N NaOH with 1 ml
1% CuS045H20 and 1 ml 2% K-Na Tartrate. BSA was used as
the protein standard.
2.4.3 Lipid peroxide Assays
Malonaldehyde (MAD), one of the major secondary
oxidation products of peroxidized polyunsaturated fatty
acids, was chosen as the representative of lipid peroxide.
Its level in both liver and skeletal muscle were determined,
using 2-thiobarblturic acid (TBA) as the reagent.
The TBA test for rat liver samples was performed by the
method of Csallany e_t aJL.. (1984). One gram of rat liver was
homogenized in a Polytron homogenizer to make a 10%
homogenate with distilled water. A 0.5 ml aliquot of the
homogenate was added to 3 ml 1% phosphoric acid and 1 ml
0.8% TBA solution. The mixture was heated for 45 minutes in
boiling water. After cooling, 4 ml of n-butanol was added
and mixed vigorously. The butanol phase was separated by
centrifugation at 800 g for 10 minutes. The absorbance of
the butanol phase was measured at both 532 nm and 520 nm.
The difference between the two readings was used to
calculated the MAD level.
The MAD measurement method in muscle was modified from
that of Csallany e_t al.. (1984). One g sample was
homogenized in a total volume of 5 ml distilled water in a
polytron homogenizer for 30 s. Then 5 ml of 10% HCIO4 was
added and the homogenate was centrifuged to precipitate the
acid insoluble protein. The clear supernatant (4 ml) was
added to 1 ml of 0.8% TBA reagent and incubated for
30 minutes in an 80°C water bath. Absorbance at 532 nm was
measured.
It should be noted that the muscle homogenate used in




The method for the determination of acid proteinase was
modified from that described by Maskrey si. 2LJL« (1977). The
enzyme activity was measured by incubating the sample for 2
hours in a final volume of 0.5 ml containing a 50 mM
CH3COONaCH3COOH buffer, (pH 3.5) and 3 mg haemoglobin. A
quantity of homogenate equivalent to 5 mg wet weight of
muscle was used. HCIO4 (1 ml 10%) was then added and, after
removing the precipitated protein by centrifugation (800 g,
20 min), the absorbance of the clear supernatant was
measured at 280 nm. The value obtained was corrected by
subtracting the blank in which the homogenate was added at
the end of the incubation. An absorbance of 1.0002h is
taken as 1 unit of activity. The hemoglobin had been
denatured before use by keeping it at pH 1.3 and 37C for lh
and subsequently- dialyzed overnight in the cold against the
50mM CH3COONaCH3COOH buffer. (pH 3.5). The concentration
of haemoglobin in the dialysate was measured by the method
described of Bradford (1976) with haemoglobin as standard,
and then diluted to the appropriate concentration.
2.4.4.2 Cathepsin B (EC 3.4.22.1)
The activity of cathepsin B was assayed by the method
of Turk and Kregar (1984) and that of Barrett (1972) with
some modifications. Using Z-Arg-NNap as the substrate, the





2-naphthylamine is released. The amount of 2-naphthylamine
2.4.4.3 Acid Phosphatase (EC 3.1.3.2)
The modified Moss (1984) method was adopted. The assay
released per unit time is determined colorimetrically by
coupling with a diazonium salt, Fast Garnet, and is
therefore a measure of cathepsin B activity.
In the assay, homogenate corresponding to 25 mg wet
weight muscle was incubated in 1 ml of 73 mM of potassium
phosphate buffer (pH 6.0), 1 mM EDTA, 2 mM cysteine, and
0.5 mM Z-Arg-NNap, at 40°C for 4 hours. Then the color
reagent was added to stop the reaction and to develop the
color. The color reagent was prepared by mixing 1.0 ml
diazonium salt solution with 0.1 ml 0.2 M NaN02 in ice for 5
minutes and then diluted with 100 fold of Mersalyl-Brij
solution. Diazonium salt solution is a 10 mM solution of.
4'-amino-2,3'-dimethylazobenzene in ethanol and water.
Mersalyl-Brij solution is a water solution containing 5 mM
of mersalyl acid, 0.8 mM EDTA and 2% of Brij 35 with a pH
value of 4.0.
The color product produced was then extracted with
butanol and the amount of 2-naphthylamine was determined by
Measuring the absorbance at wavelength 520 nm and
calibrating from the standard curve. A standard curve of 2-
naphthylamine was prepared by replacing muscle homogenate in
the assay with 2-naphthylamine in different concentration.
One unit of cathepsin B is defined as the activity
which release 1 nmole of 2-naphthylamine per minute.









Hydrolysis of p-nitrophenyl phosphate by acid phosphatase at
pH 4.9 liberates p-nitrophenol. The reaction is stopped by
raising the pH to 11 by addition of NaOH. At this pH the
strongly-colored quinonoid p-nitrophenolate ion is produced
and its absorbance is measured at 405 nm.
The assay mixture contained 6.3 mM p-nitrophenyl
phosphate, 37.5 mM citrate, 8 mM Trls at pH 4.9, and
homogenate equivalent to 5 mg wet weight muscle. After
incubating at 37°C for 10 minutes, NaOH which would give a
final concentration of 77 mM was added. Absorbance at
405 nm was then measured. A standard curve of p-nitrophenol
was obtained by substituting the muscle homogenate with a p-
nitrophenol solution. One Unit of acid phosphatase activity
is defined as the release 1 nmole of p-nitrophenol per
minute at 37c.
2.4.4.4 Catalase (EC 1.11.1.6)





The method used was based on that of Aebi (1983).
Homogenate corresponding to 2 mg wet weight muscle was added•
to a 10.5 mM solution of H2O2 in 50 mM phosphate buffer
(pH 7.0) at 25°C. The final volume of the assay was 1.0 ml.
The degradation of H2O2 was monitored by measuring the
decrease in absorbance at 240 nm since H2O2 gave high
absorption at this wavelength. One unit of catalase
activity was defined as those decompose 1 )lmole of H2O2 per
minute.
To verify that the activity measured was that of
catalase, a control containing azide (NaNg), an inhibitor of
catalase, in a final concentration of 1 mM was used
(Theorell and Ehrenberg, 1952; Cederbaum, 1987). The
difference with and without azide was interpreted as the
•actual activity.
2.4.4.5 Superoxide Dismutases (EC 1.15.1.1)
Superoxide dismutase (SOD) is a family of
metalloenzymes which is known to accelerate the spontaneous
dismutation of the superoxide radical (02,~) to hydrogen
Peroxide (H2O2) and molecular oxygen. The assay is based on
the ability of SOD to inhibit the autoxidation of
epinephrine at pH 10.2 (Misra and Fridovich, 1972). The
Production of adrenochrome in a final volume of 1 ml
containing 0.3 mM epinephrine, 0.1 mM EDTA, and 50mM .sodium
carbonate buffer (pH 10.2) at 30c was followed at 480 nm.
°ne unit of the enzyme is the amount of SOD capable of
inhibiting 50% the rate of epinephrine oxidation observed in
the control in which no enzyme was added.
To discriminate the activity of CuZnSOD from that of
MnSOD, KCN in a final concentration of 2mM was included in
the assay mixture, as described by Weisiger and Fridvoch
(1973) and Mizuno (1984). Those insensitive to cyanide was
Mnsoo while the other was CuZnSOD. in the absence of
cyanide, the activity measured was total SOD.
2.4.4.6 Malate Dehydrogenase (EC 1.1.1.37)
The method adopted to measure the activity of malate
dehydrogenase (MDH) was based on Boehringer Mannheim GmbH





Homogenate equivalent to 0.2 mg wet weight muscle was added
to a mixture containing 0.1 M phosphate buffer (pH 7,5),
0.5 mM NADH, and 1 mM oxaloacetate. The change in
sbsorbance at 340 nm at 25°C was measured. One unit MDH
Activity is defined as the amount of enzyme required to
oxidize 1 )lmole of NADH per minute at 25c.'
2.4.4.7 Lactate Dehydrogenase (EC 1.1.1.27)
Assay of lactate dehydrogenase (LDH) utilizes its
Ability to catalyze the following reaction.
pyruvate
LDH activity was determined by the rate of oxidation of
NADH. The procedure used was modified from that of Vassault
(1983). The final mixture was in a volume of 1.1 ml and was
consisting of 65 mM Tris-HCl buffer (pH 7.4), 0.3 mM NADH
and homogenate equivalent to 1 mg or 0.5 mg wet weight of
muscle. Enzyme measurement was made by continuously
monitoring the rate of change in absorbance at 340 nm at
25c. one unit of LDH activity is able to catalyze the
oxidation of 1 nmole of NADH per minute at 25°C.
2.4.4.8 Hexokinase (EC 2.7.1.1)
The following reactions are utilized for the




The procedure described by Brooks (1976) was adopted. The
final reaction mixture contained 50mM Tris-HCl buffer
(pH 7.4), 1 mM 2-mercaptoethanol, 10 mM MgCl2, 1 mM EDTA,
2.5 mM ATP, 0.4 mM NADP+, 1 mM D-glucose, 4 unit of glucose¬
s-phosphate dehydrogenase (G6P). The final volume of the
assay mixture was 1.2 ml. Change of absorbance at
wavelength 340 nm at 25°C was recorded to calculate the
enzyme activity. One unit enzyme reduces 1 pmole of NADP+
per minute at 25°C.
2.4.4.9 Alkaline Phosphatase (EC 3.1.3.1)
Alkaline phosphatase hydrolyzes p-nitrophenyl
phosphate, giving p-nitrophenolate ions, which show




The method of Boehringer Mannheim GmbH (1973) was adopted.
Homogenate equivalent to 10 mg wet weight of muscle was
added to a mixture of 98.4 mM glycine buffer (pH 10.5),
1 mM Mg2+7 0.1 mM Zn2+, and 6 mM nitrophenyl phosphatase.
The change in absorbance at 405 nm was monitored. Increase
of absorbance at 405 nm contributed by p-nitrophenolate ion
per unit time is a measure of the enzyme activity. One unit
is defined as the activity which degrades 1 nmole of p-
hltrophenylphosphate and therefore the formation of 1 nmole
of p-nitrophenolate ion per minute at 25oc.
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3.1 introduction
Alcohol is the oldest and the most common psychoactive
drug used throughout the world. Moderate drinking o£
alcohol has been reported to have a number of medical
benefits (Singer, 1972). For example, alcohol can promote
circulation and the production of blood, as well as
promoting digestion and appetite. Traditional Chinese
medical beliefs also assert that alcohol has curative
effects on rheumatism and anemia, especially for women after
childbirth. However, alcohol has the potential of being
abused.
Alcohol abuse brings about a large number of problems
which affect the person himself, his family and even the
whole community. Among the problems, the most obvious one
Is the physical damages inflicted by alcohol to the body.
Various organs and tissues in the body can be affected by
ethanol. Liver, the main site of ethanol oxidation,
displays the broadest spectrum of metabolic response and
disease as a consequence to ethanol abuse (Lieber and
BeCarli, 1977). Other tissues, including the brain (Noble
3nd Tewari, 1977), gut (Baraona and Lindenbaum, 1977), heart
(Bing and Tillmanns, 1977), endocrine systems (Gordon and
Southren, 1977), bone (Saville, 1977), blood (Lindenbaum,
177) and muscle (Geller and Rubin, 1977), can also be
severely affected and damaged by ethanol.
In this chapter, the acute effect of ethanol on
skeletal muscles is studied.
It takes a long time for human to recognize the
relation between alcohol abuse and myopathy. In 1822,
James Jackson in commenting on a 'particular disease
resulting from the use of ardent spirits' described a
progressive weakness of the limbs. Magnus Huss, in 1849,
described muscular weakness independent of a clinical
neuropathy in chronic alcoholics. Gudden, in 1896,
described three alcoholics in whom histological changes
suggested myopathy. For the half century thereafter, this
disease drew no attention (Geller and Rubin, 1977; Martin
at al., 1982).
Recent interest stems from the report of Hed et. al.
(1955) of a 53-year-old alcoholic who developed sudden pain,
tenderness and swelling of the legs. This condition
tesolved spontaneously, but recurred several times during
the next 3 years. The patient died 4 days after the onset
of severe calf pain and myoglobinuria. At autopsy the
Muscle fibers of the calf were swollen and fragmented, had
tost their striations, and were infiltrated by
Polymorphonuclear leukocytes. Hed's group then went on to
suggest a causal relationship between alcohol ingestion and
cute myonecrosis in a series of 12 patients (Hed et. al..
1962). Varying degrees of muscle damage were seen in
Muscle biopsies and severe rhabdomyolysis could be
demonstrated in all of the muscles studied at. autopsy. For
this reason, this syndrome is sometimes referred to be
alcoholic rhabdomyolysis.
Ekbom £jt 32.. (1964) described a rather different
syndrome of progressive muscle wasting and weakness in
chronic alcoholics, but without the acute features described
by Hed.
Several forms of alcoholic myopathy have been
recognized in recent years. They are the subclinical,
acute, and chronic alcoholic myopathy (Geller and Rubin,
1977). Acute alcoholic myopathy is an acute syndrome of
Muscle pain, tenderness, and edema occurring after acute
excess alcoholic ingestion. Chronic myopathy is a gradual,
insidious development of muscle wasting and weakness without
pain or tenderness (Smith, 1977). Although the chronic
myopathy is probably much more common than the acute one,
the latter is accompanied by myoglobinuria and may even
progress to death.
For a long time, acute alcoholic myopathy has not been
studied extensively because it is not a common disease and
therefore samples are limited. In addition, lacking of
proper control is reason: factors other than alcohol»•
Ingestion may be involved.
In 1980, Haller and Drachman reported an experimental
Model of acute alcoholic myopathy in rats by a combination
of prolonged exposure to ethanol and a brief period of food
deprivation. Their idea came from the fact that exposure
to high concentration of alcohol is commonly associated with
Poor nutrition. This provided an opportunity to study the
Pathology of this disease. Haller (1985) had examined the
histological features of muscle injury and repair in this
experimental model and found that the features in this model
closely parallel those in human acute alcoholic myopathy.
To study the biochemical changes in myopathy, we have
adopted the model of Haller (1985) with some modifications.
Muscular atrophy represent an increase in degradation
or a decrease in synthesis of cell components, usually the
structural proteins. Warnes e_t aj. (1981) had reported
increased rates of myofibrillar protein breakdown in a
variety of muscle-wasting diseases and these diseases may
respond to therapy directed towards an inhibition of muscle
protease activity. Therefore, the proteinase activities in
alcoholic myopathy were studied to see if increase in
proteolytic activities correspond to the atrophy.
It had been shown that ethanol may induced lipid
peroxidation in the liver (Shaw e_t al., 1981). Lipid
peroxidation may cause cell damage (Slater, 1984). Lipid
peroxides were reported to increase, in muscles of chicken,
fttice (Omaye and Tappel, 1975) and human (Kar and Pearson,
1979) with muscular dystrophies. Also, the activities of
free radical scavenging enzymes were found to be changed in
Many form of muscle atrophies (Omaye and Tappel, 1975;
Stauber et §1.., 1977; Kar and Pearson, 1979; Park et al.,
1979; Mizuno, 1984; Asayama et al.. 1986 and Burr et al..
1987). However, the involvement of free radicals in
alcoholic myopathy has not been reported. To clarify the
role of free radicals in alcoholic myopathy, the activities
°f the component enzymes of the free radical scavenging
system were investigated.
Ethanol has been reported to cause metabolic changes in
various tissues. Since muscle does not metabolize ethanol
(Martin et. a., 1982), the metabolic changes in the
alcoholic myopathy may be a consequence of other changes or
damages. By comparing the changes in this disease with
those in the other disease states, much information may be
obtained.
3.2 Materials and Methods
3.2.1 Materials
Materials used in the various assays have been
described in chapter 2. The sources of the chemicals
involved in the treatment of animals are as follows:
Ethanol (A.R. grade) from James Burrough Ltd., saccharin
from BDH, sucrose from the supermarket.
3.2.2 Animal Treatment Regimen
The treatment of rats was based on the protocol of
Haller (1985) with some modifications. Male Sprague-Dawley
rats of age 60±5 days with similar body weight were divided
into two groups. One was the experimental (ethanol-fed)
9roup while another was the pair-fed control group. Each
rt was housed in individual cage. For the experimental
9roup, ethanol solution was given as the sole drink. In
°rder to make the rats adapt to the ethanol treatment, a
special procedure was used. The initial concentration of
ethanol was 5% (vv) in tap water and then increased by 5%
in 3 day intervals until a concentration of 30% was attained
and this concentration was maintained thereafter. The
amount of ethanol intake by the rats increased from about 3g
to 14g each day per Kg body weight (see Figure 3.1).
Saccharin at a concentration of 0.05mgml was also added in
the ethanol solution to attract the rat to take the ethanol
solution. In this period, rat chow was provided ad. 1ibitum.
For the pair-fed control rats, an amount of sucrose
solution calorically equivalent to the ethanol consumed by
the experimental group in the previous day were provided as
the extra drink besides tape water. The supply of rat chow
was limited to the same amount consumed by the experimental
group in the previous day. Thus, the pair-fed controls had
calorie intakes Identical to those of the alcohol-fed rats
but did not receive alcohol.
After 24 days of ethanol treatment, rat chow was
withheld for 5 days while ethanol administration continued
In order to stimulate an alcoholic binge.
After the fasting period, rats were sacrificed by
decapitation. Muscles were then excised and homogenates
were prepared (for details, please see Chapter 2).
3.2.3 Biochemical Assays of the Muscle Homogenates
Details of the various assays have been described in
Chapter 2.
Figure 3.1 Amount of ethanol intake by rats during the
period of treatment. Each change in the
amount of alcohol given is indicated by a
arrow. E stands for ethanol solution.
3.2.4 Statistical Methods
Values have been presented as means± standard error of
the mean (s.e.m.). The significance of differences between
mean values was assessed by Student's two-tailed t-test with
a probability level of 5 per cent or less.
3.3 RESULTS
3.3.1 Gross Changes of Animals After Ethanol Administration
3.3.1.1 Body Weight
Changes in body weight of the animals during the period
of ethanol is shown as Figure 3.2. The initial average body
weight in the two groups were similar. In the first ten
days of treatment, the similarity was maintained. In the
later period, although the experimental group appeared to
have a lower body weight, the difference between the two
9oups was statistically non-significant. This non¬
significant difference may be caused by the large variation
of body weight in the experimental group which may reflect
the different susceptibility of individual animals to the
treatment. However, significant difference in body weight
appeared in the last few day of treatment when the rats were
deprived of food. The weight loss in the experimental
animals averaged 16 percent of the initial weight after 24
days of alcohol treatment while the pair-fed control animals
lost only 7% of body weight in this period. This is
comparable to the result of Haller's group (Haller and
Drachman, 1980). After an additional 5 days of fast, the
Figure 3.2 Body weight o£ ethanol treated.(E) and pair-
fed control (C) animals during the period of
treatment. Every change in the amount of
alcohol given is indicated by an.arrow. The
result are expressed as average± S.E.H.
Significant difference between the two group
occurred only on the days after the mark.
BODY WEIGHT OF
EXPERIMENTAL ANIMALS
body weight loss of the experimental group rose to 21% while
that of the control group was 18%. The difference between
the two groups became significant in this period. This may
reflect the fact that fasting manifested the effect of
ethanol on the animals.
3.3.1.2 Organ and Muscle Weight
The weights of the muscles of the hind limbs and the
various organs are shown in Table 3.1A. The percentage of
body weight values are tabulated in Table 3.IB. The weights
did not show any significant difference between the
experimental group and the pair-fed control group in all the
muscles and organs looked at with the exception of liver and
possibly the soleus.
In the muscles examined, all showed a slight decrease
In absolute weight after the treatment with the exception of
soleus which showed a very slight increase, but all
statistically non-significant. The different response of
soleus to the treatment is more obvious when the weight is
expressed as the percentage of the body weight.
For the other organs, liver showed significant decrease
in both absolute weight and percentage of body weight. On
the other hand, the spleen appeared to be increased
substantially, but the large variation in the experimental
9roup rendered the result non-significant. No significant
changes in the heart and kidney were detected.
(A) Weight (g)
Control Experimental % Change P Value
Gastrocnemius 2.313± 0.109 2.118± 0.055 -8% N. S.
ta 0.746± 0.021 0.673± 0.031 -10% N.S.
Enr
0.228± 0.011 0.209± 0.009 -8% N.S.
Soleus 0.178± 0.005 0.186± 0.005 + 4% N.S.
Heart 1.014± 0.132 1.094± 0.104 + 8% N.S.
Kidney 2.819± 0.206 2.736± 0.279 -3% N.S.
L i ver 9.528± 0.529 6.504± 0.660 -32% P0.005
sPleen 0.514± 0.041 0.654± 0.159 + 27% N.S
(B) Percentage of body weight
Control Experimental % change P Value
Gastrocnemius 0.770± 0.016 0.801± 0.014 + 4% N.S.
ta 0.248± 0.007 0.255± 0.003 + 3% N.S
EDr.
0.076± 0.004 0.079± 0.002 + 4% N.S.
Sol Alio 0.059± 0.002 0.071± 0.003 + 20% P0.005
Heav+-
0.338± 0.044 0.414± 0.034 + 22% N.S.
Kidney 0.939± 0.069 1.044± 0.117 + 11% N.S
iver 3.169± 0.167 2.457± 0.203 -22% P0.025
®Pleen 0.170± 0.013 0.241± 0.055 + 42% N.S.
lable,.
•1 Weight (A) and percentage (B) of body weight of the. ethanol
treated (Experimental) and pair-fed control (Control)
animals.% change is the percentage change of these
parameters In the experimental group as compared to the
control group.
3.3.2 Changes in Enzyme Activities in Muscles
3.3.2.1 Proteolytic Enzymes
The activity o£ total acid proteinase was assayed in
the muscle homogenates. The results are shown in
Figure 3.3. Only gastrocnemius gave a significant change in
the total activity and a significant sizable change in the
specific activity. The changes were 10% and 24% in the
specific and total activities, resoectivelv.
Since acidic proteolytic activities are mainly
contributed by lysosome, the activities of individual
snzymes were determined.
The activity of a lysosomal proteinase, cathepsin B, in
muscle homogenates of the treated and control animals was
determined and the results are shown as Figure 3.4. For
this enzyme, it was again gastrocnemius which gave
significant change in the total activity but this time it
was a decrease. The specific activity in the experimental
group was also lowered but the extent was much less and the
difference to the control was not significant statistically.
The activity of another lysosomal enzyme, acid
Phosphatase, is shown in Figure 3.5. For total activity of
gastrocnemius and EDL, a result similar to that of cathepsin
B was obtained. The total activity decreases significantly.
gastrocnemius and slightly in EDL upon ethanol treatment.
°n the other hand, the specific activity in these two
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Figure 3.3 Acid proteinase activity in muscle homogenates
o£ ethanol treated (E) and pair-fed control (C)
animals. The percentage value is the percentage
change of specific activity in the experimental
group as compared to the control group. GTS:
gastrocnemius; EDL: extensor digitorum longus;
SOL: soleus.: P0.05 as compared to the
control group. 10X stands for that the value
shown here is ten fold of- the actual value.
Specific activity is the total enzyme units
relative to the total amount of non-collagen
proteins present. Total activity is' the total
enzyme units in a muscle.
Figure 3.4 Cathepsin B activity in muscle homogenates of
ethanol treated (E) and pair-fed control (C)
animals. The percentage value is the percentage
change of specific activity in the experimental
group as compared to the control group. GTS:
gastrocnemius; EDL: extensor digitorum longus;
SOL: soleus.: P0.05 as compared to the
control group. 10X stands for that the value
shown here is ten fold of the actual value..
Specific activity is the total enzyme units
relative to the total amount of non-collagen
proteins present. Total activity is the total
enzyme units in a muscle.
Figure 3.5 Acid phosphatase activity in muscle homogenates
of ethanol treated (E) and pair-fed control (C)
animals. The percentage value is the percentage
change of specific activity in the experimental
group as compared to the control group. GTS:
gastrocnemius; EDL: extensor digitorum longus;
SOL: soleus.: P0.025 as compared to the
control group. 10X stands for that the value
shown here is ten fold of the actual value.
Specific activity is the total enzyme units
relative to the total amount of non-collagen
proteins present. Total activity is the total
enzyme units in a muscle.
elevates by 13%, similar to the situation o£ cathepsin B.
The total activity in soleus does not change, like that of
acid proteinase.
From these results, it appears that the patterns of
changes in cathepsin B and acid phosphatase in response to
the treatment are similar and these may be representative of
the lysosomal enzymes. However, for enzymes which may be
involved in the degradation of cellular components, obvious
increase cannot be observed. Therefore, the acidic
proteolytic activities may not contribute to alcoholic
Myopathy. However, the involvement of the neutral and
alkaline proteolytic activities cannot be ruled out and they
should also be determined. We have tried to measure calpairi
activities with casein yellow as the substrate as described
by Baker and Margolis (1987). However, we failed to detect
any calpain activity in the samples.
3.3.2.2 Free Radical Scavenging Enzymes
Cytochrome oxidase, superoxide dismutase (SOD),
catalase and GSH-peroxidase form the enzyme system to
scavenge the free radicals in cells. Only the activities of
catalase and SOD were assayed in this study.
The catalase activity in the muscle homogenates was
shown in Figure 3.6. In gastrocnemius and EDL, elevation in
Activity was observed. Specific activity and total activity
gastrocnemius increased by 139% and 95%, respectively.
EDL, only the specific activity increased significantly.
In soleus, no significant change was observed. This
CATALASE
figure 3.6 catalase activity in muscle homogenates o£
ethanol treated (E) and pair-fed control (C)
animals. The percentage value is the percentage
change of specific activity in the experimental
group as compared to the control group. GTS:
gastrocnemius; EDL: extensor digitorum longu's;
SOL: soleus.: PC0.005 as compared to the
control group. 10X stands for that the value
shown here is ten fold of the actual value.
Specific activity is the total enzyme units
relative to the total amount of non-collagen
proteins present. Total activity is the total
enzyme units in a muscle.
demonstrated once again that soleus respond to ethanol
treatment in a manner as compared to the other muscles
examined.
In eukaryotes, SOD generally composes o£ both CuZnSOD
and MnSOD (Fridovich, 1978). For this reason, besides the
total SOD activity, the individual activities of CuZnSOD and
MnSOD were also determined. The total SOD, MnSOD and
CuZnSOD activities were tabulated in Table 3.2, Table 3.3
and Table 3.4, respectively.
For the total SOD, only the specific activity in
gastrocnemius showed a significant decrease (Table 3.2).
EDL also exhibited a sizable decrease but not significant
statistically. On the other hand, soleus had no change.
Activity of MnSOD in EDL displayed significant decrease
in the experimental group (Table 3.3). The total activity
of MnSOD in gastrocnemius appeared to be increased, but the
increase was not significant statistically. Again, soleus
did not show any alteration in MnSOD activit'y.
CuZnSOD activity did not change significantly in any of
the muscles examined (Table 3.4).
Taken together, it seems that the free radical
scavenging enzyme activities in soleus do not alter upon
othanol treatment. The change is most obvious in
gastrocnemius in which both the specific activities of
ctalase and total SOD displayed significant changes, though
the direction of the changes of these two enzymes was
°Pposite. A similar relation was also found in EDL between
ctalase and MnSOD activities.
Specific Activity
Control Experimental % Change P Value
Gastrocnemius 32.11± 1.60 27.83± 1.73 -13% P0.005
ED.L. 33.37± 2.94 31.05± 3.04 -7% N.S.
I soleus 37.75± 0.61 38.24 ±4.20 + 1% N.S.
( Unit: u mg Protein)
Total Activity
Control Experimental % change P value
Gastrocnemius 2989± 150 2917± 208 -2% N.S.
LD.l. 270.6± 23.9 241.6± 23.6 -11% N.S,
S°leus 236.0± 3.8 245.4± 26.9 + 4% N.S.
( Unit: U Muscle
3.2 Total SOD activity in muscle homogenates of ethanol
treated (E) and pair-fed control (C) rats. Values are
expressed as average± S.E.M.% change is the
percentage change of these parameters in the
experimental group as compared to those in the control
group.
Specific Activity
Control Experimental % change P Value
Gastrocnemius 6.26± 0.12 6.16± 0.31 -2% N.S.
E.D.L. 6.69± 0.09 6.01± 0.39 -10% P0.05
Soleus 6.36± 0.51 6.32± 0.37 -1% N.S.
( Unit: U mg Protein)
Total Activity
Control Experimental % Change P Value
lstrocnemius 584.3± 20.6 646.6± 41.7 + 11% N.S.
54.25± 0.76 46.83± 3.07 -14% P0.025
I Sleus 39.78± 3.16 40.53± 2.37 + 2% N.S.
( Unit: U Muscle)
3.3 MnSOD activity in muscle homogenates of ethanol treated
(E) and pair-fed control (C) rats. Values are expressed
as average± S.E.M.% change is the percentage change
of these parameters in the experimental group as
compared to those in the control group. Specific activity
is the total enzyme units relative to the total amount of
all non-collagen proteins present. Total activity is the
total units of the enzymes in a muscle.0
Specific Activity
Control Experimental % Change P Value
Gastrocnemius 25.85± 1.61 21.67± 1.44 -16% N.S.
e.d.l. 26.68± 3.01 25.00± 3.09 -6% N.S.
soleus 31.38± 0.62 31.93± 4.56 + 2% N.S.
( Unit: U mg Protein
Total Activity
Control Experimental I% chancre P value
gastrocnemius 2405± 149 2270± 168 -6% N.S.
S-D.l. 216.3± 24.4 194.8± 24.1 -10% N.S.
S°leus 196.2± 3.8 204.9± 29.3 + 4% N.S.
( Unit: u Muscle;
3,4 CuZnSOD activity in muscle homogenates of ethanol treated
(E) and pair-fed control (C) rats. Values are expressed
as average± S.E.M.% change is the percentage change
of these parameters in the experimental group as
compared to those in the control group. Specific activity
is the total enzyme units relative to the total amount of
all non-collagen proteins present. Total activity is the
total units of the enzymes in a muscle.
3.3.2.3 Energy Metabolizing Enzymes
In this study, only the carbohydrate metabolizing
enzymes were investigated. Malate dehydrogenase (MDH) was
chosen as a representative of the enzymes in the citric acid
cycle in oxidative metabolism. The MDH results were shown
in Figure 3.7. For specific activity, only gastrocnemius
displayed a significant change in the experimental group,
i.e. an increase of 16%. In EDL and less so in soleus,
lower total activities of MDH in the experimental group were
detected. In this aspect, it seems that gastrocnemius
despond to the treatment in a different manner as compared
to the other two muscles.
Lactate dehydrogenase (LDH), the enzyme involved in the
final step of anaerobic glycolysis of carbohydrate was
assayed and the results shown in Figure 3.8. The specific
activity altered significantly only in soleus, an increase
°f 38%. In contrast, significant decreases were found in
both gastrocnemius and EDL in total activity.
Hexoklnase catalyses the phosphorylation of glucose and
Is important as a first step in glycolysis and the pentose
shunt. Hexokinase was assayed and the results were shown in
Flgure 3.9. Only in gastrocnemius a significant decrease was
detected. The activity of this enzyme appeared to be.
decreased in EDL but the difference was not significant
statistically. For soleus, the specific activity increased
slightly and the total activity had no change.
Figure 3.7 Malate dehydrogenase activity in muscle
homogenates o£ ethanol treated (E) and pair-fed
control (C) animals. The percentage value is
the percentage change of specific activity in
the experimental group as compared to the
control group. GTS: gastrocnemius; EDL•
extensor digitorum longus; SOL: soleus.:
P0.01;: P0.025;: P0.05 as compared to
the control group. 10X stands for that the value
shown here is ten fold of the actual value.
Specific activity is the total enzyme units
relative to the total amount of non-collagen
proteins present. Total activity is the total
enzyme units in a muscle.
LACTATE DEHYDROGENASE
Figure 3.8 Lactate dehydrogenase activity in muscle
homogenates of ethanol treated (E) and pair-fed
control (C) animals. The percentage value is
the percentage change of specific activity in
the experimental group as compared to the
control group. GTS: gastrocnemius; EDL:
extensor digitorum longus; SOL: soleus.:
P0.05;: P0.025 as compared to the control
group. 10X stands for that the value shown here
is ten fold of the actual value. Specific
activity is the total enzyme units relative to
the total amount of non-collagen proteins
present. Total activity is the total enzyme































































Figure 3.9 Hexokinase activity in muscle homogenates of
ethanol treated (E) and pair-fed control (C)
animals. The percentage value is the percentage
change of specific activity in the experimental
group as compared to the control group. GTS:
gastrocnemius; EDL: extensor digitorum longus;
SOL: soleus.: PC0.005 as compared to the
control group. 10X stands for that the value
shown here is ten fold of the actual value.
Specific activity is the total enzyme units
relative to the total amount of non-collagen
proteins present. Total activity is the total
enzyme units in a muscle.
To summarize the results on the energy metabolizing
enzymes, it was found that gastrocnemius exhibited elevated
MDH level but reduced level of LDH and hexokinase upon
ethanol treatment. This reflected that gastrocnemius
responds to the treatment by becoming more dependent on
oxidative metabolism. EDL, however, showed diminished
levels in all the enzymes examined. Since the activity of
EDL depends mainly on anaerobic glycolysis, the decrease in
the activities of LDH and hexokinase may represent a reduced
activity of this muscle. In soleus, decreased level of MDH
and augmented level of LDH were noticed. Hexokinase Level
displayed no change in soleus. This may suggest that soleus
shift its metabolism to anaerobic glycolysis and the source
of increased sugar requirement may be obtained through the
stored glycogen but not from the environment.
3.3.2.4 Other Enzymes
Alkaline phosphatase activity was reported to be used
Qs an indicator of sarcoplasmic reticulum and endoplasmic
Reticulum membrane integrity (Davies 1982). it was
also reported that only a low alkaline phosphatase activity
oxlsted in normal muscles and this activity would increase
severely atrophying muscle (McComb al.., 1979). For
this reason, activity of alkaline phosphatase was assayed
and the results shown in Figure 3.10.
Only in soleus a significant increase was detected.
The specific activity in gastrocnemius also increase by a






























































figure 3.10 Alkaline phosphatase activity in muscle
homogenates of ethanol treated (E) and pair-fed
control (C) animals. The percentage value is
the percentage change of specific activity in
the experimental group as compared to 'the
control group. GTS: gastrocnemius; EDL:
extensor digitorum longus; SOL: soleus.
PC0.05 as compared to the control group. 10X
stands for that the value shown here is ten
fold of the actual value. Specific activity, is
the total enzyme units relative to the total
amount of non-collagen proteins present. Total
activity is the total enzyme units in a muscle.
EDL, no change in specific activity was found while the
total activity decrease to a degree. These results may
suggest that soleus loses its membrane integrity and is
undergoing atrophy after the treatment. The same situation
way also happen in gastrocnemius but the extent is less
severe. However, this situation did not happen in EDL This
way due to that fiber Ila, which is the predominant type in
EDL, suffer the least damage after ethanol treatment.
3.4 Conclusion and Discussion
•«
Many' clinical reports stated that muscle atrophy was
found in alcoholics indicating that alcohol ingestion might
be the main cause of this pathological condition. However,
for the reason that the patients were not under strict
control and other factors, such as dietary deficiencies,
which accompanied alcohol abuse, it has been difficult to
attribute the observed muscle atrophy to alcohol ingestion
alone.
Song and Rubin (1972) tried to reproduce the alcoholic
offect on skeletal muscle by administrating alcohol to well-
Controlled human volunteers. They, found that chronic
Ugestion of ethanol for 28 days, independent of nutritional
°r other factors, leads to increased serum creatine kinase
CK) activity and striking ultrastructural• changes in
soletal muscle. However, they also found that clinical
evidence of muscular disease was noted only in a minority of
tested chronic alcoholics and the Increase in serum CK
activity appeared to be variable. Although the model was
not entirely successful, it gives support to the notion that
ethanol itself, without the contribution of other factors,
could give rise to the muscle atrophy reported.
An animal model for acute alcoholic myopathy was
developed in rats by Haller and Drachman (1980). They had
also illustrated that the histological features of the
experimental animals closely parallel the findings in
various clinical reports about the disease in human patients
(Haller, 1985). The model provides the opportunity to look
into the pathology of the disease and its biochemical basis.
Concerning the gross changes of animals in this model,
only weight loss was reported by Haller's group (Haller and
Drachman, 1980). They noted that weight loss in the..
oxperimental animals averaged 16% of the initial weight
dfter 3 weeks of alcoholic exposure (rats were kept in
9-
chamber filled with ethanol vapor and giving blood alcohol
ooncentrations in the range of 100 to 300 mg per 100 ml).
found that the experimental rats lost 16% of weight after
24 days of ethanol treatment. The two results were
etremely comparable.
It was also found that although the caloric intake was
-he same in both the ethanol treated group and the pair-fed
control group, the ethanol treated group loses its body
Weight by a greater extent, suggesting that alcohol is
Verting some effects on the whole body of the animals.
AIso, more drastic weight loss appeared in the fast period,
particularly for the ethanol treated group. It has been
shown that food Intake before alcohol ingestion can lower
the peak blood alcohol concentration, and reduces the time
required to clear alcohol from the blood (Sharma and
Moskowitz, 1978). Therefore the drastic effect of ethanol
Ingestion on the body weight in the fast period may be
caused by toxicity of alcohol which concentration was
maintained higher and for a longer time in the blood in the
absence of food intake.
Absolute and the percentage to the body of liver in the
sthanod treated rats decreased significantly. It is no
doubt that liver is the most susceptible organ to the
influence of alcohol for its role in the metabolism of
alcohol. The decreased weight may indicate reduction in
some components of the liver. This is in fact contrary to
the situation reported by Lieber (1980) who showed an
increase in liver weight after ingestion .of ethanol. Fat
deposition and liver enlargement were reported. It was
shown that lipids accounted for half the increase in the
liver dry weight (Lieber sJL., 1965), while the other half
is almost totally accounted for by an increase in proteins
(Baraona al.., 1975). But these effects appeared in the
cses of ethanol ingestion only. The weight decrease
sported in this study may be the result of the combination
ethanol treatment and fasting.
It is clear that ethanol has a differential effect on
ePatic protein synthesis (Rothschild £_L al.., 1987). A
stimulus to collagen synthesis occurs simultaneously with a
depression o£ albumin and transferrin synthesis and release.
On the other hand, it was reported that decreased intake of
dietary protein or decreased absorption of amino acids
derived from dietary protein contribute to the depletion of
amino acids in the liver (Lleber, 1980). Therefore, food
deprivation depletes amino acid supply in liver and thus
limits the extent of protein synthesis but on the other hand
the depression effect maintains. As a result, the protein
content decreases in liver and therefore giving a lower
weight after the treatment.
The heart In our experimental animals displayed certain
increase in its absolute weight and percentage of the body
weight. This agrees to the findings of various clinical
Reports which described cardiac dilation and hypertrophy
secondary to chronic alcoholism (Bing and Tillmanns, 1977).
As a result, heart diminished its contractility.
The few autopsy studies on acute alcoholic myopathy
have indicated that ethanol exerts an effect on most
skeletal muscles, including pharyngeal muscles, the strap
Muscles of the neck, and the diaphragm (Hed et aj., 1962;
Kahn and Meyer, 1970). However, for the muscles
nvestigated in this study, only soleus showed significant
°hange in percentage in the experimental' group. The
different response of soleus to the treatment agrees to the
Ending that the severity of myopathy within sampled muscles
vried according to the proportion of type I fibers
c°ntained in the muscles (Haller, 1985). So, the effect of
alcohol may be reflected In the weight of soleus In which
type I fiber predominates (Haller, 1985; Squire; 1986).
The weight increase may stem from the higher capacity
of water retention in this muscle after the treatment. This
is indicated by the result of protein concentration
determination in the muscle homogenates. The protein
concentration of homogenate of ethanol treated soleus
homogenate was 16% lower than that of the control. On the
other hand, the increase of weight may be contributed by an
elevation in fat deposition in the muscle (Song and Rubin,
1972). However, in our preliminary test of the lipid
content in the whole homogenate, little decrease was in fact
observed.
Another possible cause for the weight increase is the
Increase in connective tissue, especially the deposition of
its main component, collagen, which had been shown in the
liver of ethanol-fed animals (Lieber, 1980).
For the other muscles examined, TA was reported to be
composed of about half of type I and half of type II fibers
(Close, 1972). EDL was found to be made up of mainly type
II (lib) fibers (Close, 1972; Haller, 1985). Medial head of
gastrocnemius was shown to be a fast-contracting muscle
which contains a higher proportion of type Ila or type lib
fibers (Bowman, 1980; Simard 2,., 1985). In addition, it
was reported that in gastrocnemius most type II fibers are
lib (Brook and Kaiser, 1970). The reason why these muscles
do not display significant response to the ethanol treatment
way be due to the fact that they are not made up of
predominary type I fiber.
Electronmicroscopic examination of muscle biopsy from
patients with acute attack showed that myofibrils were
disordered, entire cells were swollen and a disarray of
organelles was noted (Geller and Rubin, 1977). Since the
order of myofibrils in a muscle is maintained by the
integrity of M-llne and z-line, the disorder of myofibrils
May imply the elevation in muscle proteolytic activities
acting on the myofibrillar proteins. Therefore, it is
valuable to find out what proteolytic activities are
involved in tfte atrophy. This may also be helpful in
probing the cause of the Increased protein degradation. In
skeletal muscle, the proteolytic activities described so far
are the lysosomal proteinases, the cytosolic proteinases
such as calpain, and some alkaline serine proteinase
originated from invading mast cells. The activities of
lysosomal proteinases and the acid proteinases were
investigated in the present study.
Lysosomal proteinases activities were found to increase
in various conditions of muscle atrophy, such as muscular
dystrophy (Katunuma and Noda, 1980), denervation (McLaughlin
!.., 1974), toxin-induced paralysis (Tgerud et al..
1986). For a long time, lysosomes were not able to be
stected in normal muscle by light or electron microscopy.
it was even suggested that the usual lysosomal enzymes
Associated with Golgi membranes or the sarcoplasmic
teticulum in muscle are not involved in the acceleration of
catabollsm o£ muscle protein (Maskrey sJL al r 1977).
However, it had been reported later that cathepsins B and D
were visualized in muscle cells lysosomes by electron
microscopy (Bird£. aX., 1980). This implies that the
assessment o£ activities o£ lysosomal enzymes may reflect
the involvement o£ lysosome in muscles.
In our study, acid proteinase activity showed signi¬
ficant increase only in the total activity of gastrocnemius.
Activity in EDL and soleus showed almost no change. On the
other hand, total activity of cathepsin B decreased signi¬
ficantly in gastrocnemius only. The opposite effect of
t«
these two enzymes in gastrocnemius implied the possibility
that there is a few types of lysosome which have different
cellular origins (Bird ai«, 1980) and that the proteinase
content of these lysosomes are different. Lysosomes
containing acid proteinases other than cathepsin B may
increase in the gastrocnemius of the ethanol treated rats
while those containing cathepsin B decrease in the same
situation. Activity of cathepsin B in EDL also decrease.
The most striking different result about cathepsin B was
hoted in soleus which showed increase in both specific
Activity and total activity. Combining with the finding of
Haller (1985) that only the muscles containing mainly type I
fibers may undergo atrophy, cathepsin B activity may
correspond to the wasting of the muscle. However., the
increase in this activity was not significant and it is
likely that other proteolytic activities are involved in the
atrophy.
In gastrocnemius, acid proteinase activity increase
while cathepsin B activity decrease. This showed that our
method of acid proteinase assay did not reflect the
situation of cathepsin B. Since the pH value in acid
proteinase assay was 3.5, it is possible that other
proteinases having optimal pH range about 3.5 increase after
the treatment. The possible proteinases are cathepsin D,
cathepsin E, or %collagenolytic cathepsin' (Barrett, 1977).
Acid proteinase activity increase only in gastrocnemius
but not in both EDL and soleus. Because that type lib fiber
exist only in a little amount in EDL and soleus (please
refer to Chapter 2), it is quite possible that the increase
in the enzyme activity was contributed by type lib fibers in
gastrocnemius•
The pattern of acid phosphatase was somewhat similar to
that of cathepsin B. In the report of Haller (1985),
increase in acid phosphatase staining in degenerating fibers
nd in the interstitium surrounding degenerating cells
Represented lysosomal activity in necrotic cells and
Phagocytes. Also, it was reported that acid phosphatase
Activity increase in atrophied fibers where muscle fiber
were replaced by connective tissue and suggesting that the
high level of enzyme activity was contributed by the
Invading cells (Beckett and Bourne, 1957). Thus, it is not
°lear whether the change in lysosomal activity observed
Represent that in the necrotic cells or that in the
Phagocytes or other invading cells. As no significant
result was found in soleus, the most susceptible muscles
proposed, it is quite possible that other proteinases would•
be involved in the wasting process.
Corresponding to the electronmicroscopic observation
that myofibrils were disordered (Geller and Rubin, 1977), it
is quite possible that calpain which had been reported to
remove the Z-line from myofibrils in the present of Ca2+ at
neutral pH was involved in the atrophy. It is because that
removal of Z-line will result in the disassembly of the
array of myofibrils. We had tried to assay calpain activity
in the muscle homogenates but failed.
Another observation in the electronmicroscopic
examination of the atrophying muscles was dilation of
endoplasmic reticulum (Geller and Rubin, 1977). It was
suspected that endoplasmic reticulum lost its integrity in
the degenerated muscles. Alkaline phosphatase activity was
reported to be used as an Indicator of sarcoplasmic
Reticulum and endoplasmic reticulum membrane integrity
(Davies si. aJL., 1982). It was also reported that alkaline
Phosphatase activity was limited to the capillaries and the
intlma of larger vessels in normal muscles and in a small
amount. This activity would increase in severely atrophying
Muscles and appear in the atrophying muscle fibers and in
the very fine connective tissue fibers surrounding them,
(Beckett and Bourne, 1957; McComb si. sLL- 1979). Activity
°f alkaline phosphatase in the ethanol treated muscles was
Examined. The result showed that significant elevated level
o£ alkaline phosphatase happened only In specific activity
of soleus. The increase activity in soleus illustrated that
only soleus underwent severe wasting. Also, it also agreed
with the assumption that the membrane of some organelles
lost its Integrity.
A significant source of membrane damage may be the
peroxidation of the lipid components of the membrane. in
liver, lipoperoxidation has been shown to be increased
following acute and chronic alcohol ingestion (videla
si. al., 1980). Also, fasting induced a greater reduction in
liver GSH content after the ingestion of ethanol. It was
also shown that content of GSH showed an inverse relation to..
the production of lipid peroxide (Videla eJi. al.- 1980). So,
fasting increase the production of lipid peroxide which may
correspond to the damage in liver. The similarity between
the condition of producing higher degree of lipid
Peroxidation in liver and the treatment we used raise the
Question whether or not lipid peroxidation occur in muscle,
for the limitation of the method of preparation of muscle
homogenate, level of lipid peroxide had not been measured,
father, some enzymes involved in the scavenging of free
Radicals were assessed.
It has been reported that alcohol-induced enhancement
°f liver lipid peroxidation occurred concomitantly with an
increase in the activity of SOD and in that of some enzymes
which generate 02~. However, no change in the activities
°f catalase and GSH peroxidase-reductase couple was found
(Valenzuela al.., 1980). These result was explained by
the increase in the generation o£ active radicals for the
induction of microsomes after chronic ethanol consumption.
(Lieber, 1980), the decrease in the antioxidant, GSH (Videla
££. SLl. r 1980), and the usual level of catalase and GSH-
peroxidase (Valenzuela al.., 1980), However, it was found
later that lipid peroxidation potentiated by ethanol
treatment in liver were not dependent on GSH depression
(Shaw et al., 1981). Free radical scavenging enzyme
activities have been studied in our model to see if this
also occurs in the muscles.
By examining the results we obtained, patterns
different from that in ethanol treated liver were observed.
Only significant decrease was found in the activity of SOD.
Also, activity of catalase increase in all the samples
examined. In the activity of catalase, CuZnSOD and total
sOD, soleus showed a different picture to the other muscles.
Contrary to the other muscles, soleus in the ethanol treated
«
9roup demonstrated almost no change in catalase activity,
whlch increase in other muscles. Soleus did not change its
total and CuZnSOD activities but gastrocnemius and EDL
showed a decrease.
If ethanol treatment also Induce the Increase in
Production of active radicals such as in liver, then the
response of gastrocnemius and EDL may protect them from the
damage of the free radicals. The lower activity of CuZnSOD
mY decrease the rate of production of the most toxic free
radical species, i.e. H2O2 and OH, which originates from
the locally toxic species, O2. The elevation o£ catalase
activity In these muscles may accelerate the scavenging o£
H2O2 and minimize the damage caused by H2O2 and 02' which
derived from H2O2.
The results also suggested that the increased level o£
catalase did not originate from the phagocytes or mast cells
which were reported to be Increased in the atrophying muscle
fibers (Haller, 1985). The results did not agree to the
suggestion that catalase could be used as an indicator o£
the degree o£ muscle wasting proposed by Stauber al..
(1977) who found an increase in catalase activity in muscles
associated with the wasting conditions of starvation,
denervation and chloroquine myopathy.
Our results do not indicate whether production of free
radicals was increased or lipid peroxidation occurred,
further information is necessary to make clear the role of
lipid peroxidation in alcoholic myopathy. However, it is
uite possible that the failure in responding to the
Increase of free radical induced by ethanol make soleus the
victim of ethanol ingestion.
The level of these enzymes in different muscle atrophy
hud also been described in various reports. Our results
Were quite different from that of denervation which
displayed alteration in free radical scavenging enzyme
Activities only in slow muscle (Asayama al.., 1986). This
be an evidence that the alcoholic myopathy does not
Involve the disorder of neural control.
Significant decrease in MnSOD activity was noted only
in edl. Decrease in MnSOD was supposed to be secondary to
decreased mitochondrial metabolic activity (Asayama ai. ai,,
1986; Burr et al.. 1987). Alternatively, as MnSOD is
located in the matrix o£ mitochondria, it was suggested that
change in activity of this enzyme would indicate the
alteration in numbers o£ mitochondria in muscle (Mizuno,
1984). To see i£ activity o£ MnSOD reflect the situation of
mitochondria, activity o£ mitochondrial enzyme, MDH, was
determined.
For the activity o£ MDH in EDL, a significant and
fairly large decrease in total activity occurred.
Statistically significant but not quite large decrease..
occurred in soleus. The result of MDH was basically similar
to that of MnSOD with the exception that specific activity
°f MDH increase to a certain extent. So the change in
Activity of MnSOD may actually be the consequence of the
change in mitochondrial function.
Then, what would the change of MDH imply in the muscle
atrophy? To answer this question, a whole view about the
metabolism in the muscle should be investigated. in
Addition to MDH, activities of LDH, a typical glycolytic
ebzyme, and hexoklnase, an enzyme corresponding to the
Uptake of glucose, were assayed.
In gastrocnemius, activities of LDH and hexokinase
decrease while that of MDH increase. This may imply that
9astrocnemius depend more on the oxidative metabolism of
Pld after the ethanol treatment. In EDL, all enzymes
e3amlned showed decreased activity. This may Indicate that
the metabolism in EDL decrease perhaps as a result of less
exercise.
In soleus, activities of MDH and hexokinase decreased
in a small scale and almost unchanged, respectively.
However, activity of LDH elevated markedly. This
illustrated that soleus had shifted its metabolism from the
oxidative one to anaerobic glycolysis. Also, it seemed that
the source of the substrate for the increase in glycolysis
does not come from the blood but from an internal source.
This agreed to the observation of Haller (1985) that loss of
9lycogen was found in necrotic muscle fibers. He had also
Proposed three possible sources of the loss of glycogen...
They were the Increased energy utilization in the cell, the
reduced capacity for oxidative metabolism, and the influx of
calcium and sodium which activate various ATPase,
Accelerating the hydrolysis of ATP and promoting
9lycogenolysis. From our result, it was believed that it
wds the higher energy requirement in the muscle' which caused
the increase use of the stored glycogen. However, it was
n°t clear that how the change pattern of metabolism relate
the degeneration.
To compare these results with that from the denervation
dtrophy, different pattern can be observed. In denervated
mUscles, soleus showed decrease activity of all these•
en2ymes. EDL exhibited decreased activity in LDH and MDH
kdt elevated level in hexokinase. Gastrocnemius displayed
same pattern as EDL (Simard§£ slL.., 1985). However, the
ethanol treated soleus had a much increased LDH activity and
unchanged MDH and hexokinase activity. This is also a proof
that disorder of nerve control is not involved in alcoholic.
myopathy.
In DMD, necrotic muscles showed normal level of mito¬
chondrial enzymes, reduced level of glycolytic enzymes and
Increased level of hexokinase (Ellis, 1978). The pattern
was also different to that of alcoholic myopathy. This
shows that no common metabolic change happened in the
different type of muscle atrophy.
As a conclusion, the results obtained suggest that
lysosomes are not actively involved in the degeneration
Process, that active free radical species may involve in the
Necrotic muscles causing the loss of integrity of the
°rganelle membrane, and that the soleus shift its metabolic
Pattern from that of the oxidative one to glycolysis
utilizing mainly the glycogen stored. Also, the data
Proposed that disorder of nerve control is not the cause of
this type of myopathy.
Further experiments to be done may be the direct
Measurement of the level of lipid peroxide in the ethanol
treated muscle to see if the process is actually involved in
damage. Also, the activities of proteinases other than
lysosomal ones are worth looking into to clarify the
r°le of proteinases in the atrophy. If their roles are
Purified, then inhibitors of these proteinases or
ntioxidants may be tested to see if any amelioration of the
syndrome can be resulted.
CHAPTER 4 EFFECT OF DENERVATION AND CLENBUTEROL TREATMENT
ON SKELETAL MUSCLES
4.1 Introduction.. .107
4.2 Materials and Methods.. .112
4.2.1 Materials .112
4.2.2 Animal Treatment Regimen.., .112
4.2.3 Biochemical Assays o£ Muscle Homogenates.. 113
4.2.4 statistical Method.... 114
4. 3 Results.. .. .114
4,3.1 Gross Changes o£ Animals.. ,114
4.3.1.1 Body Weight,. .114
4.3.1.2 Organ Weight... .118
4.3.1.3 Muscle Weight... .124
4.3.2 Biochemical Changes.. . .137
4,3.2.1 Energy Metabolizing Enzymes .137
4.3.2,2 Proteinases.. .151
4.3.2.3 Lipid Peroxide and Free Radical
Scavenging Enzymes .171
•4 Conclusion and Discussion. . .191
4,1 introduction
As described in chapter 1, motor nerve exerts a trophic
effect on skeletal muscle. If the nerve to a muscle is
severed, the muscle will gradually waste over a period of
weeks. This process is termed denervation atrophy and it is
a demonstration that the muscle fibers are dependent upon
the motoneurons for the maintenance of their normal
structure (McComas, 1977). In this process, a series of
physiological, biochemical, and morphological changes occur.
The most obvious change in the muscle following
denervation is muscle atrophy which can be detected a few
days after denervation and it goes on for a period of rapid
t«
progression. At the end of this period, only 20-40% of the
original muscle mass remains (Sunderland and Ray, 1950). A
large portion of the remaining mass is connective tissue.
Fine structure of denervated muscle fiber has also been
examined with the electronmicroscope (Pellegrino and
Franzini, 1963; stonnlngton and Engel, 1973). During the
period of atrophy the change in fiber area was matched
throughout by a fall in the mean area of the myofibrils.
Mitochondria in both type I and type II fibers enlarged at
first in the longitudinal axis of the fiber. Subsequently
these organelles shrank and formed clusters. Some
Mitochondria underwent frank degeneration and were included
autophagic vacuoles. similarly the sarcoplasmic
Reticulum at first enlarged and then diminished. other
changes observed under the electronmicroscope included
abnormalities of the Z-disc, irregularities and small
papillary projections o£ the sarcolemma, and focal
dilatations of the transverse and sarcoplasmic tubules.
Increased numbers of ribosomes were found between the
myofibrils and under the surface membrane.
The change in the membranous structures, mitochondria
and sarcoplasmic reticulum may be caused by membrane
disorder induced by the peroxidation of the membrane lipid
components. Increased catalase activity has been observed
in denervated skeletal muscle (Stauber£. al..,. 1977).
Asayama aJL- (1986) showed that CuZnSOD and GSH-peroxidase
decreased significantly in slow muscle but not in fast
muscle, on the other hand, the MnSOD activity was found to•
decrease in both types of muscles but greater in the slow
twitch muscle. However, there is no report on the level of
lipid peroxide in denervated muscles. Thus, the correlation
between organelle changes and lipid peroxidation remains to
be established. Nevertheless, the MnSOD activity was
believed to reflect mitochondrial free radical production
and in turn a function of mitochondrial metabolic activity
(Asayama et al., 1986).
It was reported that in denervated rat calf muscles
there was a rapid decrease in the high enzyme activities
typical of a particular type of fiber, such as glycolytic
enzymes in fast twitch muscles and citric acid cycle enzymes•
ln slow twitch muscles (Hogan al.. 1965; Romanul and
hogan, 1965). As a result fiber types could no longer be
distinguished. Since the different types of fibers were
typical in their contraction properties and mainly the
metabolic pathway they adopted, the examination in energy
metabolizing enzymes in denervated fibers will give
information about the nerve-controlled phenotypic expression
of different skeletal muscle fiber types. Results of Simard
si. al.( 1985) showed that EDL and gastrocnemius seem to be
more oxidative after denervation. Shackelford and Lebherz
(1981) showed that neural information, or its consequences,
is required to maintain the levels and the rates of
synthesis of glycolytic enzymes in mature fast-twitch muscle
fibers. They suggested that denervation results in a
Partial 'dedifferentiation• of these fibers. Histochemical
••
study showed that denervation increased type II fibers in
at soleus muscle (Jaweed si. aJ., 1955) and produced an
occlusive atrophy of type II fibers in rat EDL muscle
(Niederle and Mayar, 1978). Thus, the proportions of
histochemical fiber types also indicated a dedifferentiation
°f muscle types after denervation.
By comparing the effects of denervation and disuse on
he rates of oxidation and on activities of mitochondrial
snzymes, Nemeth sJL sLL (1980) suggested that nerve regulate
oxidative processes in type I fiber by maintaining their
Mitochondrial enzymes, a mechanism different from that in
type II fiber.
On the other hand, the change in activities of energy
Metabolizing enzymes also reflects the shift of energy
3°urce in the denervated muscles, in denervated slow and
fast muscles, enzymes for anaerobic glycolysis, lactate
fermentation, citric acid cycle and 3-oxidation had a
decreased activity (Simard £i al., 1985). While in
sciatectomized muscles, a 5-£old elevation in alanine and
aspartate aminotransferases was reported (Asotra and Asotra,
1984). This revealed that increased utilization of amino
acids function as a compensatory metabolic support during
denervation atrophy.
The source of the amino acids for the increased
utilization may be the degradation of structural proteins in
the denervated muscles. Goldspink (1976) revealed that
after denervation protein breakdown was Increased in both
muscle types when compared with internal controls. This
happened 24 hours after denervation and maintained at least
10 days thereafter.
The increased protein breakdown is possibly caused by
an increase in proteinase activities. increases in
lysosomal acidic proteinases activity (McLaughlin et al..
1974; Maskrey si 1.., 1977; Libelius si ai., 1981) and in
calpain activity (Elce gi si., 1983; Hussain si al.., 1987)
have been reported.
Denervation of skeletal muscle also results in well
defined physiological changes derived from changes in the
Muscle surface membrane systems. Sarcolemmal membrane
changes include increased membrane resistance and sodium
Permeability, decreased potassium permeability and resting
Membrane potential, increased acetylcholine sensitivity, and
increased synapse-forming potential (smith and Appel, 1977).
Maltln ai. aJL. (1986b) reported that dietary adminis¬
tration of clenbuterol, a fl2 selective adrenoceptor agonist
growth promoter, inhibits and reverses denervation-induced
atrophy in rat soleus. This raises the possibility that in
patients with diseases which are caused by the destruction
of motoneurons or by lesion of the peripheral nerves this
drug can be used to retard the atrophy process until muscles
are reinnervated. It is better if the effect of this drug
is specific to the denervated muscle and does not cause
changes in other components of the body. Later, by
measuring the fractional rate of protein synthesis and
muscle protein and RNA contents, Maltin ai,.. (1987b)
showed that in denervated muscles only half of the protein
anabolism was achieved through reduced degradation, the
Remainder resulted from a stimulation in rate of protein
synthesis.
However, the biochemical basis of the ameliorative
effect of clenbuterol has not been investigated. Also, 32-
Adrenergic receptor has been reported in skeletal muscle
fibers but its function is still not clearly defined (Walton
And Mastaglla, 1981). Thus, the study of the interaction of
Adrenergic activation and denervation may provide a clue to
the function of the adrenergic receptor in skeletal muscle.
In this study, the effect of denervation on lipid
Peroxidation and on free radical scavenging enzyme
Activities has been studied, in addition to the biochemical
Effects of clenbuterol administration on denervated muscles.
4.2 Materials and Methods
4.2.1 Materials
Materials used in the various assays have been
described in Chapter 2. Clenbuterol tbenzyl alcohol, 4-
amino--(t-butylamino )methyl-3, 5-dlchloro] used in the
treatment o£ rats is a HCl-salt donated by Biomedla Foscama
Industria Chimico-Farmaceutica S.P.A. The drug is dissolved
in normal saline for injection.
4.2.2 Animal Treatment Regimen
A number' of experiments using different treatment
regimens had been performed, Including rats with different
ages and with different periods and different amounts of
clenbuterol treatment.
For adult animals, male Sprague-Dawley rats of age
60+5 days with body weight ranging between 350 and 400 g
were used. In each experiment, 4 groups of 10 rats with
similar initial body weight were used. For young animals,
immediately weaned male Sprague-Dawley rats were used. They
were usually 28+2 days old and weighed about 100 g. in
this experiment, 4 groups of 15 rats were.used.
For the four groups of rats in an experiment, two
groups were denervated while the others were sham-operated.
During the operation, animals were anesthetized with ether.
The sciatic nerve of the two hindlimbs In the hip region was
exposed. About 1 cm of the nerve was removed in the
denervated groups but not the sham-operated groups. The
skin and subcutaneous tissue were then closed with clips.
One denervated group and one sham-operated group were
injected intraperitoneally with clenbuterol while the other
two groups were treated with saline as control. Clenbuterol
and saline injection were started on the next day after the
operation. in experiment to determine the time effect,
adult rats were killed 4 days (acute effect) or 2 weeks
(long term effect) after the operation. The dosage of
clenbuterol used was 0.2 mgkg body-weight per day. In
experiment to determine the age effect, animals were killed
1 week after the operation and the clenbuterol dosage used
was 0.6 mgkg body-weight per day.
In the experiment using different doses of clenbuterol,
the doses used were 0.2 mg, 0.6 mg, 1 mg and 2 mgkg body-
weight per day. The rats used were adult ones and were
killed after 1 week of the operation. In another
experiment, rats were not treated with clenbuterol and they
were killed after different periods of the denervation:
1 week, 2 week and 4 week.
After the period of treatment stated above, rats were
sacrificed by decapitation. Muscles were then excised and
homogenate3 were prepared (see chapter 2).
4.2.3 Biochemical Assays of Muscle Homogenates
Details of the various assays have been described in
Chapter 2.
4.2.4 Statistical Method
All data are presented as means± standard error of the
mean (S.E.M.). For determination of the effects of
different factors (denervation and clenbuterol treatment),
data were assessed by the analysis of variance (ANOVA) for
the completely randomized two-factor design, on the other
hand, the significance of differences between mean values
were examined by t-test (LSD method). The probability level
for significance is 5 percent or less.
r
4.3 RESULTS
4.3.1 Gross Changes of Animals
4.3.1.1 Body Weight
Change in the body weight in the time course experiment
is shown in Table 4.1. The body weight of denervated rats
became smaller than the control rats. By analyzing with
F test for one factor, the P value obtained was smaller than
0.05 and thus the effect of denervation on body weight was
significant.
Such an effect of denervation on the body weight of the
experimental animals is also shown in Table 4.2 in which
%
tats were subjected to acute (4 days) or long-term (2 weeks)
denervation. Control rats increased their body during the
experimental period and such increases were not signi¬
ficantly affected by clenbuterol administration. Denervated
Table 4.1 Body weight o£ rats with hind limb denervation
for different periods of time
Time Weight (g)
Control 461.7± 12.6a
One Week 437.5± 7.3ab
Two Weeks 439.2± 5.9ab
Four Weeks 424.6± 7. 0b
Values with same superscript letters are not significantly
different.
Denervation of the hind limbs was achieved by removing about
1 cm of sciatic nerve at the hip region under ether
anesthetization, in the control rats, only sham-operation
was suffered. In the sham-operation, the nerve was exposed
only.
rats also increased their body weight, but to a much less
extent. Such truncated increase in body weight appeared to
bo slightly restored by clenbuterol administration but the
effect is not statistically significant (Table 4.2).
The inability of clenbuterol to alter body weight
changes in control and denervation rats is also demonstrated
h Table 4.3 in which different doses of the drug were used
and in Table 4.4 for adult rats with one week treatment,
or young rats, however, denervation had no effect on body
wcight increases and clenbuterol appeared to accelerate such
Whereases in both control and denervated groups, but the
Effect is not significant statistically (Table 4.4).
Table 4.2 Body weight increase in rats with acute and long
term treatment o£ denervation and clenbuterol
administration















Values are in unit of gram.
NS; Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Denervation method has been mentioned
in Table 4.1. Clenbuterol was dissolved in normal saline and
was administrated intraperitoneally. In the control groups,
saline instead of clenbuterol was injected.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
As a whole, it seems that denervation represses the
increase in body weight of adult rats but not that of young
tats. Clenbuterol treatment has no effect on both the
control and denervated groups as far as body weight is
concerned. The decrease in body weight increment in the
dult rats may be a consequence of less food intake. It was;
because that after denervation the legs of the rats were
bardly to afford the heavy body to attain the rat chow which
placed at the top of the cage. The young rats with a
Table 4.3 Body weight changes in normal and denervated rats
treated with clenbuterol in different doses
Dose Denervated Rats Control Rats P Value
0. Omg 0.00± 2.04d 38.75± 3.15ab
0. 2mg 7.50± 6.61d 35.00± 4.56ab
0. 6mg 20.00± 2.89c 31.25± 8.99b
1. Omg 5.00± 2.04d 42.50± 4.33a




Values are expressed in unit of gram.
Doses are in unit of mgkg body-weight per day.
Methods of denervation and clenbuterol administration has
been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
Table 4.4 Body weight changes in young and adult rats with
denervation and clenbuterol treatment
Young Rats Adult Rats
NS 55.67± 16.2a
NC 63.00± 22.la












Values are expressed in unit of gram.
Ms; Normal, saline-treated; NC: Normal, clenbuterol-
cieated; DS: Denervated, saline-treated; DC: Denervated,
cienbuterol-treated. Methods of denervation and clenbuterol
Administration has been described in Table 4.1 and 4.2.
b: Significance of denervation caused effect; c:
significance of clenbuterol treatment caused effect; Dc:
significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
much lower weight and thus it was easier for them to reach
the rat chow. The fact that clenbuterol cannot change the
weight of the rat supposed that its effect was a localized
one. To verify this assumption, the organ weight and muscle
weight of rats with clenbuterol administration were
examined.
4.3.1.2 Organ Weight
The fact that denervation and administration of
clenbuterol in different doses have no effect on weight of
liver and heart is shown in Table 4.5 in which the absolute
weight is listed and in Table 4.6 in which the percentage
weight is recorded. Although it was not affected by
denervation, kidney weight was decreased by clenbuterol.
The most significant effect was found when the dose used was
0.6 mgkg body-weight per day. It is not surprise that
denervation has no effect on organ weights since it is a
localized effect. The data, however, also showed that
clenbuterol exerted only localized effect on the rats. The
decreased kidney weight in clenbuterol administrated rats
toay be a result of that clenbuterol was excreted through
kidney and in this process it induced damage to kidney and
lowered its weight.
The organ weights in the young rats experiment are
shown in Table 4.7. For liver, the interaction effect was
significant in both the absolute and percentage weight.
clenbuterol treatment reversed the significant increase in
Table 4.5 Organ weight of denervated and normal rats with
treatment of clenbuterol in different doses
Liver (D: P=0.058; C: N.S.; DC: N.S.)
Dose Denervated Rata Control Rats
0. Omg 14.98± 0.95ab 16.91± 1.20a.
0. 2mg 14.67± 1.02ab 14.05± 0.76b
0. 6mg 15.25± 1.49ab 14.99+ 1. 27a
1. Omg 13.44± 0.45b 17.12± 0.64a
2. Omg 14.43± 0.20ab 15.50± 0.50ab
Kidney (D: N.S.; C: P0.01; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 1.749± 0.028ab 1.790± 0.073a
0. 2mg 1.596± 0.045bcd 1.679± 0.024abcat-
0. 6mg 1.573± 0.053cd 1.502± 0.067d
1. Omg 1.631± 0.083abcd 1.677± 0.069abc
2. Omg 1.603± 0.049bcd 1.668± 0.036abcd
to be continued
Table 4.5 (continued)
Heart (D: N.S.; C: N.S.; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 1.366± 0.061c 1.469± 0.085bc
0. 2mg 1.379± 0.047c 1.348± 0.034c
0. 6mg 1.652± 0.120ab 1.408± 0.055bc
1. Omg 1.604± 0.077abc 1.513± 0.054bc
2. Omg 1.789± 0. 269a 1.491± 0.071bc
Values are expressed in unit of gram.
hoses are in unit of mgkg body-weight per day.
Methods of denervation and clenbuterol administration has
been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
liver weight caused by denervation both in terms of absolute
wdght and percentage of body weight. Clenbuterol treatment
alone had no effect.
%
In kidney a similar effect was observed. Denervation
Ihcreased both the absolute weight and percentage of body
Weight. Clenbuterol treatment, however, decreased kidney
Weight on both normal and denervated rats but with a much
tked effect on the denervated one. As a result,
clenbuterol restored the increased kidney weight in
Table 4.6 Percentage organ weight of denervated and normal
rats treated with clenbuterol in different doses
Liver (D: P=0.060; C: N.S.; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 3.941± 0.250ab 4.099± 0.292ab
0. 2mg 3 .924± 0. 273ab 3.650± 0.197ab
0. 6mg 3.587± 0.351b 4.066± 0.343ab
1. Omg 3.513± 0 .118b 4.320± 0.162a
2. Omg 3.623± 0.050b 3.936± 0.127ab
Kidney (D: N.S.; C: P0.01; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.460± 0.007a 0.434± 0.018ab
0. 2mg 0.427± 0.012ab 0.436± 0.006ab
0. 6mg 0.370± 0.012c 0.407± 0:018bc
1. Omg 0.427± 0.022ab 0.423± 0.017ab
2. Omg 0.403± 0.012bc 0.424± 0.009ab
to be continued
Table 4.6 (continued)
Heart (D: N.S.; C: N.S.; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.359± 0.016bc 0.356± 0.021bc
0. 2mg 0.369± 0.013bc 0.350± 0.009c
0. 6rag 0.389± 0.028abc 0.382± 0.015bc
1. Omg 0.419± 0.020ab 0.382± 0.014bc
2. Omg 0.449± 0. 068a 0.379± 0.018bd
Doses are in unit of mgkg body-weight per day.
Methods of denervation and clenbuterol administration has
been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
enervated animals to its control value.
As in the adult rats, both the absolute and percentage
lights of heart and spleen did not alter significantly
a£ter denervation or treatment with clenbuterol.
As a whole, denervation had significant effect on the
liver and kidney weight of young rats but not on adult rats.
clenbuterol appeared to restore the increased organ weights
denervated rats to their control value.
Table 4.7 Organ weight of young rats with denervation and
clenbuterol treatment





















K Absolute weight (g)
NS 0.882± 0. 031ab
NC 0.816± 0. 020b









































. to be continued
Table 4.7 (continued)






















L: liver; K: kidney; H: heart; S: spleen
NS: Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Methods of denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; c:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
4'3.1.3 Muscle Weight
The absolute and percentage muscle weights in the
Experiment addressing the dose effect of clenbuterol are
3hown in Table 4.8 and Table 4.9, respectively. In all the
mhscles investigated, denervation caused a significant
decrease in the absolute weight and percentage of body
Weight. clenbuterol alone had no significant effect, but
the drug appeared to be partially effective in restoring the
Uscle weight decrease inflicted by denervation.
In the experiment in which the time effect was inves-
Table 4.8 Muscle weight o£ denervated and normal rats
treated with clenbuterol o£ different doses
Gastrocnemius (D: P0.001; C: N.S.; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 1.497± 0.080c 2.340± 0.097a
0. 2mg 1.725± 0.048bc 2.352± 0.121a
0. 6mg 1.871± 0.046b 2.238± 0.187a
1. Omg 1.757± 0.015bc 2.300± 0.076a
2. Omg 1.739± 0.209bc 2.232± 0 .097a
TA (D: P0.001; C: N.S.; DC; N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.540± 0.030d 0.801± 0.057a
0. 2mg 0.594± 0.007cd 0.810± 0. 021a
0. 6mg 0.665± 0.032bc 0.755± 0.032a
1. Omg 0.634± 0.009cd 0.791± 0 .018a
2. Omg 0.582± 0.064cd 0.777± 0.043a
EDL (D: P0.001; C: N.S.; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.172± 0.009e 0.229± 0.013ab
0. 2mg 0.177± 0.007e 0.215± 0.010abcd
0. 6mg 0.199± 0.021bcde 0.223± 0.011abc
1. Omg 0.194± 0.006cde 0.232± 0.014a
2 .Omg 0.186± 0.018de 0.211± 0.005abcd
to be continued
Table 4.8 (continued)
Soleus (D: P0.001; C: N.S.; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.124± 0.006d 0.188± 0.011a
0. 2mg 0.134± 0.009cd 0.180± 0.005a
0. 6mg 0.147± 0.014cd 0.171± 0.008ab
1. Omg 0.143± 0.006cd 0.188± 0.005a
2. Omg 0.150± 0.008bc 0.191± 0. 006a
Values are expressed In unit o£ gram.
Doses of clenbuterol used are in unit of mgkg body-weight
Per day.
Ta: Tibialis anterior; EDL: Extensor digitorum longus•
Methods of' denervation and clenbuterol administration has
b®en described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; Dc:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
tigated, the muscle weights are shown in Table 10 and
Table 11. Table 10 shows the muscle weight in rats with
acute treatment while Table 11 shows that in rats with long
term treatment. For the acute treated groups, denervation
caused significant decrease in both percentage weight and
absolute weight of gastrocnemius, TA and soleus but not that
°£ EDL. Clenbuterol treatment did not cause any significant
Iteration in the muscle weights, both in control and
Table 4.9 Percentage muscle weight o£ denervated and normal
rats treated with clenbuterol in different doses
Gastrocnemius (D: P0.001; C: P0.05; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.394± 0. 018c 0.568± 0.015a
0. 2mg 0.463± 0.015b 0.610± 0.011a
0. 6mg 0.443±. 0.027bc 0.604± 0.018a
1. Omg 0.461± 0.014b 0.581± 0.016a
2. Omg 0.434± 0.035bc 0.566± 0.010a
TA (D: P0.001: C: P=0.054; DC: N.S.
Dose Denervated Rats Control Rats
0 .Omg 0.142± 0. 007c 0.194± 0.006a
0. 2mg 0.160± 0.008bc 0.211± 0 .003a
0. 6mg 0.157± 0.008bc 0.206± 0.008a
1. Omg 0.166± 0.006b 0.200± 0.008a
2. Omg 0.145± 0.010c 0.197± 0.006a
EDL (D: P0.001: C: P0.05: DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.045± 0.0006e 0.055± 0.002bc
0. 2mg 0.048± 0.001d€ 0.056± 0.001bc
0. 6mg 0.047± 0.002de 0.061± 0.001a
1. Omg 0.051± 0 .002cd 0.059± 0. 003ab
2. Omg 0.047± 0.003d« 0.054± 0.0006°
to be continued
Table 4.9 (continued)
Soleus (D: P0.001; C: P=0.070; DC: N.S.)
Dose Denervated Rats Control Rats
0. Omg 0.033± 0.002c 0.046± 0.001a
0. 2mg 0.036± 0.001bc 0.047± 0.0004a
0. 6mg 0.035± 0.002bc 0.047± 0.001a
1. Omg 0.038± 0.001b 0.048± 0.001a
2. Omg 0.038± 0.0003b 0.049± 0.002a
Values are expressed as percentage of body weight.
Doses of clenbuterol used are In unit of mgkg body-weight
Per day.
TA: Tibialis anterior; EDL: Extensor digitorum longus
Methods o£ denervation and clenbuterol administration has
been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different,
enervated groups.
In the long term treatment experiment, denervation
induced significant decrease in both the absolute and
Percentage weight of all the muscles investigated. In this
Experiment, significant effect of clenbuterol can also be
°bserved in gastrocnemius and TA in which clenbuterol can
Partially restored the weight decreases inflicted by
enervation while the drug alone has no effect. No
Table 4.10 Muscle weight o£ rats with acute treatment of
denervation and clenbuterol





















T Absolute weight (g) Percentage of body weight
NS 0.873± 0 .018a
NC 0.891± 0.011a



































S Absolute weiaht Percentage of body weight
NS 0.213± 0.008a
NC 0.192± 0.004b


















Q; gastrocnemius; T: tibialis anterior; E: extensor
digitorum longus; S: soleus
Ns: Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Methods of denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; Dc
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
influence of clenbuterol on EDL and soleus was observed.
The age effect of denervation and clenbuterol treatment
Was also examined. The result in adult rats and in young
ats are shown in Table 4.12 and Table 4.13, respectively.
ln both batches of animals, denervation caused significant
decline in both the absolute and percentage weights of all
muscles looked at. in the adult rats, clenbuterol
increased the weight of gastrocnemius and soleus but the
Effect was not specific to denervated rats. Clenbuterol had
Table 4.11 Muscle weight of rats with long term treatment



















































































s Absolute weight (g) Percentage of body weight
NS 0.213± 0.006a


















G; gastrocnemius; T: tibialis anterior; B: extensor
dlgitorum longus; S: soleus
NS: Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated, Methods of denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
ho effect on EDL and TA, either when used alone or on
enervated animals. In the young rats, clenbuterol had no
affect when used alone but the drug is capable of restoring
Partially the weight losses of denervated gastrocnemius, TA
ahd soleus, but not of EDL.
On the whole, it was found that the effect of
enervation on muscle weight, both in terms of the absolute
hd the percentage, was very marked. However, EDL responded
denervation slowly and thus its weight did not change











































































































G; gastrocnemius; T: tibialis anterior; E: extensor
digitorum longus; s: soleus
NS: Normal, saline-treated; NC i Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Methods o£ denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: Significance o£ denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
significantly 4 days after denervation. From the long term
effect of clenbuterol on gastrocnemius and TA, it may be
concluded that these muscles may respond to a low dose (0.2
togkg body-weight per day) of clenbuterol only when the
Period of administration is long enough. With comparison to
the muscle weight of the animals treated with a higher dose
0.6 mgkg body-weight per day) of clenbuterol for one week
{see Table 4.12), it was suggested that soleus responds
Table 4.13 Muscle weight of young rats with denervation and
clenbuterol treatment
G Absolute weight (g) Percentage of body weight
NS 0.744± 0.015a 0.480± 0.010a
NC 0.780± 0.022a
D:





P0.001 0.286± 0. 004c
C:
P0.005
DC 0.545± 0. 013b
DC:
P0.05 0.329± 0. 006b
- DC:
P0.005
T Absolute weight (g) Percentage of body weight






DS 0.174± 0. 005c
C:








E Absolute weight (g) Percentage of body weight
NS 0.082± 0.003a 0.053± 0.001a
NC 0.084± 0.004a
D:



































3; gastrocnemius; T: tibialis anterior; E: extensor
dlgitorum longus; S: soleus
NS: Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Methods o£ denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: Significance o£ denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly.
different.
better to a higher dose of clenbuterol than a longer
treatment period. However, TA responds better to a long
Administration period, instead.
In young rats, with the exception of EDL, muscles are
Very sensitive to clenbuterol treatment. Also, the
interaction effect of denervation and clenbuterol treatment
wbich was hardly observed in adult rats was also significant
in the muscles of young rats.
Body weight and muscle weight in the experimental
animals illustrated the localized effect of clenbuterol on
rats. The body weights of both adult and young rats did not
respond to clenbuterol administration but the muscle weights
increased significantly. Also, clenbuterol effect may be
age-dependent. clenbuterol affected the organ weight of
young rats but not that of adult rats.
4.3.2 Biochemical Changes
4.3.2.1 Energy Metabolizing Enzymes
The alteration of metabolic activities in denervated
muscles has been studied rather extensively (Turner and
Manchester, 1972; Nemeth si. a-L., 1980; Max§£ al.., 1981;
Shackelford and Lebherz, 1981; Evans, 1983; Moruzzi and
Bergamini, 1983; Asotra and Asotra, 1984; Simard sjfc. aJL.r
1985; shoji, 1986). But the effect of clenbuterol on the'
Metabolism of denervated muscles has not been reported.
Two energy metabolizing enzymes were studied in our
r-
experiment. They were malate dehydrogenase (MDH) and
lactate dehydrogenase (LDH). MDH is a component enzyme of
the citric acid cycle and is regarded as the representative
°f enzymes involved in oxidative metabolism. LDH is' the
ehzyme involved in the final step of anaerobic glycolysis
ahd its level may reflect the activity of this process.
In rats subjected to acute treatment, denervation
caused significant effect on both MDH specific and total
Activity of all the muscles studied (Figure 4.1). In




























Figure 4,1 MDH activities in muscles of rats with acute
denervation and clenbuterol treatment. Dose of
clenbuterol used was 0.2 mgkg body-weight per
day and the treatment was lasted for 4 days.
Methods of denervation and clenbuterol
administration have been described in Table 4.1
and 4.2. The table above shows the significant
contribution of the different factors studied.
D: Significance of denervation caused effect; c
: Significance of clenbuterol treatment caused
effect; DC: Significance of the Interaction
effect of denervation and clenbuterol treatment;
N.S.: non-significant. For a muscle, columns




































































































































Figure 4.2 MDH activities in muscles of rats with chronic
denervation and clenbuterol treatment. Dose of
clenbuterol used was 0.2 mgkg body-weight per
day. Methods of denervation and clenbuterol
administration have been described in Table 4.1
and 4.2. The table above shows the significant
contribution of the different factors studied.
D: Significance of denervation caused effect; C
: Significance of clenbuterol treatment caused
effect; DC: Significance of the interaction
effect of denervation and clenbuterol treatment;
N.S.: non-significant. For a muscle, columns






































































































































Figure 4.3 MDH activities in muscles o£ adult rats with one
week denervation and clenbuterol treatment.
Dose o£ clenbuterol used was 0.6 mgkg body-
weight per day. Methods o£ denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with


































Figure 4.4 MDH activities in muscles o£ young rats with one
week denervation and clenbuterol treatment.
Dose o£ clenbuterol used was 0.6 mgkg body-
weight per day. Methods o£ denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with




































































































gastrocnemius and EDL, both specific and total activities
declined significantly after denervation. However,
denervation augmented the MDH specific activity in soleus
but diminished the total activity. Clenbuterol treatment
also induced significant effect on the specific activity of
MDH. The effect on gastrocnemius and soleus was a decrease
in activity while that on EDL was a increase in activity.
As a result, clenbuterol restored the influence of
denervation on EDL and soleus, although the effect was not
specific to the denervated rats.
The long term effect on MDH activities was shown in
Figure 4.2. As in acute treated rats, denervation caused
significant changes in both specific and total activities of
all the muscles examined, all decreased this time.
Clenbuterol treatment triggered significant effect only in
the total activity of gastrocnemius and the specific
activity of soleus. Elevation in total activity of gastroc¬
nemius was a result of clenbuterol administration while
decrease in specific activity was the ca3e in soleus. In
total activity of gastrocnemius, the effect was specific to
the denervation caused decrement.
MDH activities in the experiment with adult animals %'
administrated with a higher dose (0.6 mgkg body-weight per
3ay) of clenbuterol for one week are shown in Figure 4.3,
with the exception of the total activity in soleus,
denervation generated significant reduction in both specific
and total activity in all the muscles investigated.
Clenbuterol treatment alone exerted no significant effect on
all the data shown, clenbuterol appeared to restore the
denervation decreased enzyme activity partially in the total
activity of EDL and the specific activity of soleus.
Figure 4.4 shows the MDH activity in young rats.
Denervation caused a decrease in all the activities examined
with the exception of specific activity in gastrocnemius.
Clenbuterol administration had no effect on the activity in
soleus. Clenbuterol Increased both the specific and the
total activities in EDL and the total activity in gastroc¬
nemius. No effect of clenbuterol detected was specific to
denervation.
On the whole, denervation caused significant change in
the MDH activities with the exception in young rat gastroc¬
nemius. In gastrocnemius of adult rats, decreased MDH
activities appeared not later than the fourth day after the
operation, in EDL, a reduced MDH activity was found in all
situations investigated. However, specific MDH activity in
soleus increased on the fourth day after.the operation and
decreased at the following time examined. This may reflect
the fact that soleus, a slow twitch muscle which obtained
its energy mainly from oxidative metabolism, responses to
denervation differently from the fast twitch muscles.
Lower specific MDH activity was-found in adult gastroc-
hemius after the acute treatment with clenbuterol. This
change disappeared when the treatment was maintained. After
long term administration, however, clenbuterol increased the
total activity of MDH and thus reversed the effect exerted
by denervation on this muscle. In the young rats,
clenbuterol administration also Induced an increased level
o£ total MDH activity in gastrocnemius. Effect of
clenbuterol administration on EDL was mainly an increase in
the MDH activity. With the exception of the long term
treated rats, elevated MDH activity appeared in EDL after
clenbuterol administration. Administration of a large dose
of clenbuterol for one week increased and restored the
denervation caused decrease in total MDH activity in EDL.
In soleus, MDH activity decreased when a low dose of
clenbuterol was used but increased and was restored
partially to its normal value when a high dose was used.
Another energy metabolizing enzyme assayed was LDH.
LDH activities in acutely treated rats are shown in
Figure 4.5. Denervation decreased the enzyme activity in
control gastrocnemius and EDL significantly. in gastroc¬
nemius, clenbuterol lessened the enzyme activity only in the
control muscles. In EDL, clenbuterol increased LDH activity
in the denervated muscles but decreased it in the control
muscles. As a result, clenbuterol administration restored
partially the decrement caused by denervation. Increased
specific LDH activity was found in denervated soleus. Only
the specific activity in control soleus was elevated signi¬
ficantly.
For the long term treated animals, LDH activities are
shown in Figure 4.6. Denervation caused significant
decrease in both specific and total activities in gastroc-
























Figure 4.5 LDH activities in muscles of rats with acute
denervation and clenbuterol treatment. Dose of
clenbuterol used was 0.2 mgkg body-weight per
day. Methods of denervation and clenbuterol
administration have been described in Table 4.1
and 4.2. The table above shows the significant
contribution of the different factors studied.
D: Significance of denervation caused effect; C
: Significance of clenbuterol treatment caused
effect; DC: Significance of the interaction
effect of denervation and clenbuterol treatment;
N.S.: non-significant. For a muscle, columns
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Figure 4,6 LDH activities in muscles o£ rats with chronic
denervation and clenbuterol treatment. Dose o£
clenbuterol used was 0.2 mgkg body-weight per
day. Methods o£ denervation and clenbuterol
administration have been described in Table 4.1
and 4.2. The table above shows the significant
contribution of the different factors studied.
D: Significance of denervation caused effect; C
: Significance of clenbuterol treatment caused
effect; DC: Significance of the interaction
effect of denervation and clenbuterol treatment;
N.S.: non-significant. For a muscle, columns











nemius. clenbuterol treatment expressed its effect of
increasing LDH activity only on the total one in this
muscle. The effect of clenbuterol was specific to neither
the control nor the denervated muscles. Only denervation
induced significant effect on LDH activity in EDL. It
lowered both the specific and total activity. Clenbuterol
treatment had no effect on this muscle. Denervation caused
significant decrease only in LDH total activity in soleus.
Similar to that in EDL, clenbuterol treatment had no effect
on LDH activities in this muscle.
LDH activities in rats treated with a high dose of
clenbuterol for one week are shown in Figure 4.7. In
•«
gastrocnemius, only the total activity was affected by
denervation significantly. A decreased enzyme level was
found. There was no significant change of LDH activity in
gastrocnemius after clenbuterol treatment. In EDL, the sole
influence of the treatment was that clenbuterol decreased
the specific activity in the denervated muscle. In soleus,
denervation decreased significantly the specific activity of
LDH and clenbuterol treatment reversed the denervation
induced effect significantly. For total activity,
clenbuterol treatment elicited a significant elevated level
of LDH in soleus.
Figure 4.8 shows the LDH activities in young rats.
Specific activity in gastrocnemius was affected by neither
denervation nor clenbuterol treatment. Denervation reduced
but clenbuterol treatment elevated the total activity of LDH


























Figure 4.7 LDH activities in muscles of adult rats with one
week denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.6 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with






















































































































Figure 4.8 LDH activities in muscles o£ young rats with one
week denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.6 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant, For a muscle, columns with






Spe. Act/ Total Act.
Spe. Act. Total Act.
Spe. Act Total Act.
In gastrocnemius, in the factors studied, only denervation
caused significant effect in EDL. Decreased LDH activity
was resulted. No significant difference was found in the
specific activity values in soleus with different treatment.
For the total activity, Denervation caused a much lowered
enzyme level while clenbuterol treatment restored the value
to the control level.
On the whole, in gastrocnemius, denervation Induced
decrease in activity developed as time went on. The process
was fairly slow since the effect could not be seen in
muscles which had been denervated for one week. In this
aspect, young rats showed similar trend as the adult ones.
•
Acute effect of clenbuterol elicited a decrease in LDH
activities while long term treatment gave an increase in
activity. in young rats, increased LDH activity was also
found after clenbuterol treatment. In EDL, denervation
caused a decreased enzyme activity. Effect of clenbuterol
treatment can only be observed in the acutely treated rats.
Clenbuterol resumed the lost activity in the denervated
Muscles. The same situation was found in young rat. In
3oleus, denervation elicited an increased level of LDH first
Md then shifted gradually to a reduced level. In the young
rats, however, no significant change in specific activity
was observed after denervation. Clenbuterol treatment
Meliorated the effect of denervation on soleus. The same
situation was also found in young rats.
For the energy metabolizing enzymes investigated, it
was found that the effect of denervation and clenbuterol
treatment was fairly similar in the same muscles.
4.3.2.2 Proteinases
Denervation caused atrophy is related to a higher
degree of protein degradation (Goldspink, 1976) which is
usually a consequence of increased proteolytic activity.
Also, it was reported that clenbuterol reversed the atrophy
through both a higher protein synthesis rate and a lower
protein degradation rate in denervated muscles (Maltin
si ai-f 1987b). For this reason, the proteinase activities
in the muscle homogenate of the treated rats were assayed to
see if clenbuterol treatment exerted an effect on.. the
proteinase activities.
First of all, activity of acid proteinase was
determined. Increased specific acid proteinase activity was •
found in the muscle of acutely treated rats (Figure 4.9).
por total activity, denervation caused significant effect
°nly in EDL. Clenbuterol treatment increased acid
Proteinase activity only in soleus. The same effect of
clenbuterol was found in both denervated and control
Muscles.
The long term effect of clenbuterol treatment on acid
Proteinase activity is shown in Figure 4.10. As in the
cute treated rats, denervation elicited significant
elevation of specific activity in all the muscles examined.
clonbuterol treatment had its effect on specific activity
°hly in EDL. The influence of clenbuterol was specific to
Muscles Activity D C DC
Gastrocnemius
Specific P0.025 N.S. N.S.
Total N.S. N.S. N.S.
EDL
Specific P0.001 N.S. N.S.
Total PC0.005 N.S. N.S.
Soleus
Specific P0.001 P0.001 N.S.
Total N.S. PC0.005 N.S.
Figure 4.9 Acid proteinase activities in muscles of rats
with acute denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.2 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with same
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Figure 4.10 Acid proteinase activities in muscles of rats
with chronic denervation and clenbutero]
treatment. Dose of clenbuterol used was
0.2 mgkg body-weight per day. Methods oi
denervation and clenbuterol administration havs
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance oi
denervation caused effect; C: Significance oi
clenbuterol treatment caused effect; DC:
Significance of the interaction effect oi
denervation and clenbuterol treatment; N.s.:
non-significant. For a muscle, columns witl












the denervation induced increased enzyme level. For the
total activity, significant effect of the clenbuterol
administration was found only in gastrocnemius. Both
denervation and clenbuterol treatment increased the total
activity in gastrocnemius.
In adult rats treated with a large dose of clenbuterol,
effect of treatment is shown in Figure 4.11. Denervation
Increased all the activities detected except the total
activity in gastrocnemius. Clenbuterol treatment decreased
the specific acid proteinase activity in EDL while increased
the specific and total activity in soleus. Clenbuterol
treatment restored the denervation induced change in EDL.
In young rats, denervation increased the specific and
total activity in all the muscles examined (Figure 4.12).
Significant effect of clenbuterol was found in the total
activities in all the muscles studied. The total activities
were elevated after clenbuterol administration.
Clenbuterol treatment resumed the denervation induced
elevated soecific acid proteinase activity in aastrocnemius.
As a summary, it was found that denervation usually
increased the activity of this enzyme in adult rats after
different period of operation and in young rats with
°peration one week before. Effect of clenbuterol treatment
was significant in soleus of all animals except those with
clenbuterol administration lasted for two weeks. But this
affect was mainly an increase in acid proteinase activity.
In adult rats, clenbuterol treatment only exerted an effect
specific to the denervation caused change in EDL. This
Muscles Activity D C DC
Gastrocnemiu:
Rnr1f1( Po. 025 M C N S
















Figure 4.11 Acid proteinase activities in muscles of adult
rats with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.s.:
non-significant. For a muscle, columns with
































































































































Figure 4.12 Acid proteinase activities in muscles o£ young
rats with one week denervation and clenbuterol
treatment. Dose o£ clenbuterol used was
0.6 mgkg body-weight per day. Methods o£
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution o£ the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with











effect can only be observed when the treatment was lasted
for over one week. Clenbuterol treatment reversed the
Increase in acid proteinase activity induced by denervation.
Significant effect of clenbuterol administration in gastroc¬
nemius can only be found in the young rats, in this case,
clenbuterol also reversed the denervation elicited increased
enzyme activity.
Activity of cathepsin B, a lysosomal enzyme, was also
determined to see the influence of the treatment on a
specific proteinase. The enzyme activities in acute treated
rat muscles are shown in Figure 4.13. Denervation had no
•«
effect in gastrocnemius. In EDL and soleus, denervation
caused an Increase in both specific and total activity.
Also, clenbuterol exerted significant effect on cathepsin B
activity in these muscles, in control muscles, clenbuterol
increased the enzyme activity. In denervated muscles,
however, the activity was unchanged in soleus or decreased
«V
in EDL. As a result, clenbuterol administration inverted
the denervation caused increase of cathepsin B activity in
EDL. Clenbuterol increased the enzyme activity in soleus of
Cnnfrnl an I ma 1 a rn 1 7
In long term treated rats, cathepsin B activity was
determined only in EDL and soleus (Figure 4.14). In EDL,
denervation Increased the specific activity significantly.
Clenbuterol treatment had no effect. Denervation caused a
significant increase in specific activity and a significant
decrease in the total activity in soleus. The effect of
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Figure 4.13 Cathepsin B activities in muscles of rats with
acute denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.2 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; Dc:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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Figure 4.14 Cathepsin B activities in muscles of rats with
chronic denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.2 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.
non-significant. For a muscle, columns with







Spe. Act. Total Act.
Soleus
Spe. Act. Total Act.
clenbuterol treatment was specific to the control muscles in
both the specific and the total activities. it decreased
the enzyme activity in control muscle significantly.
The cathepsin B activities in adult rats treated for a
week are shown in Figure 4.15. In control gastrocnemius and
soleus, significant increase of cathepsin B activity was not
resulted after denervation, in EDL, however, denervation
induced significantly elevated level of this enzyme.
Clenbuterol elicited significant rise in cathepsin B
activity in gastrocnemius and in the specific activity in
soleus. Clenbuterol induced a significant increase in
cathepsin B activity in denervated gastrocnemius and
denervated soleus but restored partially the denervation
caused increased enzyme activity in EDL.
Denervation increased significantly the specific
activity of cathepsin B in gastrocnemius and soleus
(Figure 4.16). Clenbuterol administration increased the
total activity of cathepsin B in both gastrocnemius and EDL.
In gastrocnemius, clenbuterol restored partially the
denervation caused increase in enzyme activity.
On the whole, the effect of denervation on cathepsin B
activity in adult rats was significant in both EDL and
soleus. However, the effect on gastrocnemius developed
slowly. On the fourth day after denervation, no effect of
denervation in gastrocnemius was observed, in young rats,
increased cathepsin B activity was found only in gastroc¬
nemius and soleus.


























Figure 4.15 Cathepsin B activities in muscles o£ adult rats
with one week denervation and clenbuterol
treatment. Dose o£ clenbuterol used was
0.6 mgkg body-weight per day. Methods o£
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution o£ the
different factors studied. D: significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with








































Figure 4.16 Cathepsin B activities in muscles of young rats
with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; c: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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Effect of clenbuterol treatment was much more
complicated than that of denervation. For gastrocnemius,
acute treatment caused lower activity only in control muscle
while the one week treatment caused higher activity only in
the denervated muscle. In young rats, clenbuterol treatment
restored the denervation induced rise of cathepsin B
activity. In EDL, clenbuterol treatment reversed the effect
elicited by denervation within the first week of treatment
but this effect could not be obtained after two weeks of
treatment. This effect was not observed in the young rats.
In soleus of adult rats, clenbuterol treatment elevated the
cathepsin B activity in the control muscle after four days'
of treatment but decreased this activity in the control
muscle after tvo weeks of clenbuterol treatment. No effect
of clenbuterol was found in denervated soleus. In young
rats, clenbuterol treatment reduced the denervation caused
increase in the activity of this enzyme. However, the
result was not significant statistically due to the large
errors in the result.
Activity of another lysosomal enzyme, acid phosphatase,
was also determined. This can provide more information
about the involvement of lysosome in the treatment.
The time course of denervation on this enzyme is shown
in Figure 4.17. In gastrocnemius, denervation had no signi¬
ficant effect on the specific activity for a long time.
After four weeks, acid phosphatase activity decreased its
Activity. The activity of this enzyme increased with time
Figure 4.17 Acid phosphatase activities in muscles of rats
as a time course of denervation. Method of
denervation has been described in Table 4.1.
For a muscle, columns with same letters at





























































































after denervation in EDL and soleus. The increase in soleus
stopped two weeks after denervation. The fact that total
activity in gastrocnemius increased one week after
denervation may be a reflection of the relative high protein
concentration in the denervated rat muscle homogenate. The
decrease in total activity in all the muscles was caused by
the denervation induced reduction in muscle weight.
Acid phosphatase activity in muscles of acutely treated
rats shown in Figure 4.18. Denervation increased the
specific activity of all the muscles examined significantly.
Clenbuterol exerted significant effect only in soleus
.i
specific acid phosphatase activity. in control muscles
clenbuterol increased this activity but it decreased this
activity in denervated muscles. Clenbuterol administration
reversed the denervation induced effect. The total activity
was elevated in EDL and lowered in soleus by denervation.
Significant effect of clenbuterol treatment was found only
in soleus. The change in total activity was opposite to
that in specific activity in soleus. The total activity may
be a reflection of the change in muscle weight as the unit
Activity (activity per gram muscle) was almost similar.
Figure 4.19 shows acid phosphatase activities in rats
subjected to long term treatment. For specific activity,
significantly increase activity was found in all the muscles
Probed after denervation. Clenbuterol treatment lowered the
specific activity in denervated gastrocnemius and EDL signi¬
ficantly. Clenbuterol treatment also decreased this
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Figure 4.18 Acid phosphatase activities in muscles of rats
with acute denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.2 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: significance of
clenbuterol treatment caused effect; Dc:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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Figure 4.19 Acid phosphatase activities in muscles of rats
with chronic denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.2 mgkg body-weight per day. NS: Normal,
saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC:
Denervated, clenbuterol-treated. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; c: significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with


















































































activity in the normal muscles. In soleus, the effect of
clenbuterol was significant and no specific effect was
found. Decreased activity of total acid phosphatase
occurred only in gastrocnemius and soleus.
In adult rats with one week treatment, the pattern of
acid phosphatase specific activity was somewhat similar to
that with two week treatment (Figure 4.20). However, the
effect of clenbuterol treatment in this experiment was not
as significant as that with two week treatment. As a
result, significant decrease in specific enzyme activity was
found only in EDL. For the total activity, all changes
could be found were the elevated activity in EDL and soleus
after denervation.
In young rats (Figure 4.21), both the specific and
total activities were increased in all the muscles
investigated after denervation. Clenbuterol treatment
exerted a significant effect on the specific activity in
gastrocnemius. The denervation induced increased activity
was diminished. Only total activity in soleus exhibited a
significant response to clenbuterol treatment. However,
clenbuterol treatment increased the activity in control
muscle and enhanced the denervation caused rise in activity.
To conclude, it was obvious that denervation developed
increased level of acid phosphatase although the result in
Figure 4.17 does not agree to this completely. The effect
of clenbuterol treatment was not as obvious as that of
denervation. In adult animals, after four days of treatment
(acute treatment), only soleus showed significant response




























Figure 4.20 Acid phosphatase activities in muscles of adult
rats with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the Interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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Figure 4.21 Acid phosphatase activities in muscles of young
rats with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.
non-significant. For a muscle, columns with
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to the clenbuterol treatment. Clenbuterol reversed the
change caused by denervation. This effect developed later
in all the muscles. However, it was not significant in
soleus after two week of treatment. In young rats,
clenbuterol administration restored the increase in acid
phosphatase activity caused by denervation only in gastroc¬
nemius.
It was quite obvious that the proteinase activities
Increased after denervation in all the muscles studied.
Clenbuterol treatment can reverse the denervation caused
effect in the acid proteinase activity on EDL and the young
gastrocnemius, in the cathepsin B activity on young gastroc¬
nemius and the adult EDL, and in the acid phosphatase
activity on the adult muscles and young gastrocnemius. It
seems that clenbuterol treatment is most effective in
reversing the denervation caused rise in proteinase activity
in the adult EDL and young gastrocnemius. Both of them are
fast twitch muscles.
4.3.2.3 Lipid Peroxide and Free Radical Scavenging Enzymes
To investigate the contribution of free radicals on the
damage of denervation and if clenbuterol treatment effects
on this mechanism of damage, the degree of lipid
peroxidation and activities of free radical scavenging
enzymes were assayed. The extent of lipid peroxidation was
evaluated through the amount of malonaldehyde (MAD) existed
in muscles. The enzymes assayed were catalase and
superoxide dismutase (SOD).
Table 4.14 Malonaldehyde content in muscles and liver of


















NS 0.123± 0. 004a













Values shown here are absorbance at 532 nm for muscles and
the difference of absobance at 532 nm and 520 nm after the
homogenates reacting with thiobarbitaric acid.
EDL: Extensor digitorum longus
NS: Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Methods of denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.

Amount o£ MAD in muscle homogenates and in liver was
determined only in the adult rats with one week of
treatment. The amount of MAD is shown in Table 4.14 as the
value of absorbance at 532 nm after the reaction of muscle
homogenate with thlobarbituric acid (please refer to
Chapter 2 for the details of the method). In all the
muscles investigated, the absorbance value showed a trend of
decrease in the denervated muscle but this was not signi¬
ficant statistically. Both denervation and clenbuterol
treatment had no significant effect on lipid peroxide in
muscle. However, clenbuterol treatment caused significant
rise in amount of MAD in liver of control animals.
The first enzyme to be assayed was catalase. It is
responsible for the degradation of H2O2 which is produced by
the dismutation of oxygen radical originated in many
cellular processes.
The time course of denervation effect on the muscles is
shown in Figure 4.22. In gastrocnemius, the enzyme activity
increased by almost two fold one week after the operation.
The enzyme level then decreased gradually. In EDL and•
soleus, the enzyme activity was also increase by almost two
fold after one week but the activity was maintained at this
level for a period more than four weeks. The decrease in
the total activity was a consequence of the much lowered
muscle weight after the operation for a certain time.
The dose effect of clenbuterol treatment on gastroc-
Figure 4.22 Catalase activities in muscles of rats as a
time course of denervation. Method of
denervation has been described in Table 4.1.
For a muscle, columns with same letters at
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Figure 4.23 Dose effect of clenbuterol on catalase
activities of denervated and control gastroc¬
nemius. Dose of clenbuterol used was in unit of
mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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nemius was also investigated (Figure 4.23). From the
figure, it can be seen that denervation caused a much higher
v
catalase activity while clenbuterol treatment restored the
enzyme activity back to the control level. At a drug dose
of 0.6 mg to 1.0 mg, the control enzyme level was attained.
It was also noted that clenbuterol treatment had no effect
on the control muscles. Therefore, the interaction effect
of clenbuterol administration and denervation was signi¬
ficant.
Catalase activities in acute treated animals are shown
in Figure 4.24. Denervation induced elevation in catalase
activity in gastrocnemius but clenbuterol treatment reversed-
this effect and lowered the high enzyme activity.
Clenbuterol showed different effect on denervated and
control muscles. In EDL, denervation had no effect on the
muscles treated without clenbuterol. But clenbuterol
treatment in this muscle let the enzyme activity become much
lower in the denervated muscles. In soleus,' clenbuterol
treatment exerted opposite effect on the control and
denervated muscles. It increased and decreased the enzyme
activity in control and denervated muscles, respectively.
It restored the denervation induced enzyme activity
affectively. But clenbuterol itself induced a high catalase
activity in the control muscle.
Pattern similar to that of the acute experiment was
found in gastrocnemius of rats subjected to long term
treatment (Figure 4.25). In EDL and soleus, denervation
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Figure 4.24 Catalase activities in muscles of rats with
acute denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.2 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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Figure 4.25 Catalase activities in muscles o£ rats with
chronic denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.2 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: significance of
denervation caused effect; c: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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caused significant increased catalase activity and
clenbuterol treatment could not reversed this effect.
Moreover, clenbuterol treatment lowered the enzyme activity
in control soleus. The total activity showed a similar
pattern to that in specific activity with the fact that the
effect of denervation was not so obvious for the muscle
weight loss.
In adult rats with one week treatment, the effect of
denervation and clenbuterol treatment on catalase was
determined (Figure 4.26). Denervation elevated the enzyme
activity significantly in all three muscles. Clenbuterol
treatment reversed the effect of denervation. In soleus,-
however, clenbuterol decreased the catalase activity in the
control m» ft r 1=« ft.
Effect of treatment in young rats is shown in
Figure 4.27. No change was found in EDL. In gastrocnemius
and soleus, similar patterns were obtained. Denervtion
increased the specific activity in denervated muscles and
clenbuterol treatment reversed this effect specifically. No
significant information was obtained from the total
activity.
To take a whole view about the catalase activity, it
was noted that effects of denervation and clenbuterol
treatment on gastrocnemius was significant in all situations
investigated. Effect of denervation on EDL was not signi¬
ficant four days after the operation. However, the effect
was significant one week or longer after the operation. in
EDL of the young rats, there was still no significant























Figure 4.26 Catalase activities in muscles of adult rats
with one week denervation and clenbutero]
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods oi
denervation and clenbuterol administration havs
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance oi
denervation caused effect; C: Significance oi
clenbuterol treatment caused effect; DC:
Significance of the interaction effect oi
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with




























Figure 4.27 Catalase activities in muscles of young rats
with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; Dc:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with













































































































denervation effect one week after the operation.
Clenbuterol decreased catalase activity in the denervated
EDL when the treatment period was very long, in soleus, the
effects of denervation and clenbuterol treatment was signi¬
ficant four days and one week after the treatment. But
these effects disappeared after two week treatment. The
effects were also significant in the young rats.
Table 4.15 Catalase activity in hemolysate of rats with
denervation in hind limbs and clenbuterol
treatment
















Values are expressed as enzyme unitml hemolysate in volume
activity and enzyme unitmg protein in specific activity.
Hemolysate was prepared as that descibed by Matkovics£. al.
(1982).
NS: Normal, saline-treated; NC: Normal, clenbuterol-
treated; DS: Denervated, saline-treated; DC: Denervated,
clenbuterol-treated. Methods of denervation and clenbuterol
administration has been described in Table 4.1 and 4.2.
D: Significance of denervation caused effect; C:
Significance of clenbuterol treatment caused effect; DC:
Significance of the interaction effect of denervation and
clenbuterol treatment; N.S.: non-significant
Values with same superscript letters are not significantly
different.
Catalase activity in hemolysate was also determined
(Table 4.15). It was found that only denervation exerted
significant effect on the enzyme activity. As in the
muscle, catalase activity was elevated by denervation. This
may showed that the denervation effect on catalase activity
was not specific to the muscle.
Another free radical scavenging enzyme studied was SOD.
There are two types of SOD, CuZnSOD and MnSOD. Both of them
were measured in our experiment. The total SOD activity was
also determined. Figure 4.28 shows the change of MnSOD in
adult rats. No significant effect was found in specific
activity of all the muscles studied. Denervation exerted
its effect only in the total activity in gastrocnemius and
soleus. It decreased the enzyme activity in gastrocnemius
while increased the enzyme activity in soleus.
In young rats, MnSOD was also mostly unaffected by the
two factors Investigated. Significant difference was found
only in the total activity in gastrocnemius (Figure 4.29).
As a conclusion, it seems that MnSOD activity was not
affected by denervation and clenbuterol treatment.
Activity of CuZnSOD in adult rat muscles is shown in
Figure 4.30. A picture similar to the MnSOD activity was
found. No significant change in specific activity was
found. Denervation caused rise in total catalase activity
In soleus and decrease in the total activity in gastroc¬
nemius.
Figure 4.31 shows the effect of denervation and




























Figure 4.28 MnSOD activities in muscles of adult rats with
one week denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.6 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with








































Figure 4.29 MnSOD activities in muscles of young rats with
one week denervation and clenbuterol treatment.
Dose of clenbuterol used was 0.6 mgkg body-
weight per day. Methods of denervation and
clenbuterol administration have been described
in Table 4.1 and 4.2. The table above shows the
significant contribution of the different
factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with
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Figure 4.30 CuZnSOD activities in muscles of adult rats
with one week denervation and clenbuterolsA.
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with










































































































































Figure 4.31 CuZnSOD activities in muscles of young rats
with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with


































































































clenbuterol treatment on the CuZnSOD activity in young rats.
In EDL and soleus, no significant effect was observed. In
gastrocnemius, denervation increased the enzyme activity
while clenbuterol treatment restored it to the control
level.
Therefore, only the CuZnSOD in gastrocnemius of young
rats was affected by denervation and clenbuterol treatment.
The pattern of total SOD activity in denervated and
clenbuterol treated adult rats was quite similar to that of
CuZnSOD (Figure 4.32). This may show that MnSOD level was
reasonably unchanged after the treatment and total SOD
activity was actually a reflection of the CuZnSOD activity.
For activity in EDL, denervation caused an increased level'
of enzyme and clenbuterol treatment restored it to the
control level. On the other hand, as the result of CuZnSOD,
denervation induced an increased enzyme activity in soleus
and a decreased activity in gastrocnemius.
The total SOD activity in young rats (shown in
Figure 4.33) was also similar to that of CuZnSOD. For the
specific activity, denervation caused an increase in enzyme
activity while clenbuterol treatment contributed its effect
by reversing the denervation caused increase in enzyme
activity. Total activity in all the muscles investigated
was increased by denervation.
Only EDL in adult rat and gastrocnemius in young rat
showed significant response in their specific activity to
denervation and clenbuterol treatment. No significant


























































































































gure 4.32 Total SOD activities in muscles o£ adult rats
with one week denervation and clenbuterol
treatment. Dose o£ clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; DC:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.:
non-significant. For a muscle, columns with same





































9ure 4.33 Total SOD activities in muscles of young rats
with one week denervation and clenbuterol
treatment. Dose of clenbuterol used was
0.6 mgkg body-weight per day. Methods of
denervation and clenbuterol administration have
been described in Table 4.1 and 4.2. The table
above shows the significant contribution of the
different factors studied. D: Significance of
denervation caused effect; C: Significance of
clenbuterol treatment caused effect; Dc:
Significance of the interaction effect of
denervation and clenbuterol treatment; N.S.
non-significant. For a muscle, columns with






On the whole, it was found that the level of lipid
peroxide was not changed with either denervation or
clenbuterol administration. For catalase activity,
denervation caused significant increase and clenbuterol
treatment reversed this effect in gastrocnemius, soleus, and
adult EDL. There was no change in MnSOD activity after the
treatment. The treatment had its effect on the total SOD
and CuZnSOD activities in only the young gastrocnemius and
adult EDL. This is fairly consistent with the result of the
proteinase activity.
4.4 Conclusion and Discussion
Denervation of skeletal muscle is resulted by the
interruption of the normal activity of the motor nerve to a
skeletal muscle caused either by disease or severe
mechanical injury. Usually the muscle will be reinnervated
either by the regenerated fiber or a nearby fiber (McComas,
1977). However, these processes need time and in the period
reinnervation is going on the denervated muscle undergoes
atrophy. After a few weeks of atrophy, much of the mass of.
the muscle is replaced by connective tissue (Sunderland and
Ray, 1950). In this situation the muscle can no longer
function properly even if reinnervation occurs. Thus, drugs
inhibiting or ameliorating the atrophy process in denervated
muscles may be helpful.
Clenbuterol, a -adrenergic agonist, has been reported
to ameliorate denervation-induced atrophy in rat soleus
muscles (Maltin sJl al.., 1986b). This drug was reported as a
growth promoting substance in Increasing muscle growth
(Baker aJL• 1984; Ricks aJL., 1984). The growth
promoting effect has been attributed to modifications of
protein turnover (Emery g£ al.., 1984; Reeds si al.., 1986).
It has been shown that the ameliorative effects of
clenbuterol in denervated rat muscles were due principally
to a large increase in protein synthesis. The rest of the
observed the protein anabolism was achieved through reduced
deqradation (Maltin et al., 1987b).
However, besides protein turnover, there are numerous
other biochemical changes occurring in denervated muscles.
These may also contribute to the atrophy process.
Gross changes in animals under clenbuterol adminis¬
tration gives the most basic information about the
treatment. At first, by investigating the time effect, the
dose used was according to the result of Reeds gt. al.. (1986)
and was 0.2 mgkg body-weight per day. However, after
examining the dose effect of clenbuterol on gross changes
such as body weight (Table 4.3), muscle weight (Table 4.8
and Table 4.9) and organ weight (Table 4.5 and Table 4.6), a
dose of 0.2 mgkg body-weight per day was found to be too
small to induce a significant effect. As a result, a higher
dose (0.6 mgkg body-weight per day) was used in subsequent
experiments in which the age effect was studied.
For body weight, denervation represses its increase in
adult rats but not in young rats. Although clenbuterol
administration did not increase the body weight in adult
rats, it was obvious that body weight o£ young rats were
increased. Raised body weight gain by treatment with
clenbuterol in young rats was also reported by Emery gj..
(1984). These show that elevated body weight gain can only
be obtained in young rats.
In the organs studied, only liver and kidney respond to
the treatment significantly. Denervation increase their
weights while clenbuterol administration restored them to
the control values. It has been reported that clenbuterol
does not affect the weight of kidney and liver after 7 days
(Emery air, 1984) and 15 days (Reeds §JL., 1986)
treatment. Our result is consistent with these observation.
Clenbuterol had no effect on the control rats. Moreover, in
our experiment, it was found that clenbuterol restored
partially the denervation induced weight increase in these
organs. Heart weight has also been reported to be higher in
clenbuterol treated rats after 15 days of treatment (Reeds
et al.. 1986). This effect was not found in our experiment.
This may be caused by the shorter treatment period we used.
In denervated muscles, the proteolytic activity-
Increases and thus more amino acids are released. It was
also reported that activities of alanine and aspartate
aminotransferases increase significantly in denervated
muscles and it was suggested that increased utilization of
amino acids function as a compensatory metabolic support
during denervation atrophy. When amino acids are used as
the energy source, the problem that the amino acid nitrogen
must be transferred from muscle to liver happens. The
glucose-alanine cycle was proposed (Mallette e£. §1.., 1969;
Felig si. sLL- 1970). After muscle denervation, more amino
acids would have to be transferred to liver. This will
enlarge the amino acid pool in liver and probably stimulate
protein synthesis in liver. Thus, liver increases its
weight. Restoration of liver weight in clenbuterol treated
denervated rats may be a result of the lower protein
degradation in denervated muscles or a result that the 3
agonist inhibits the amino acid release in skeletal muscle
(Garber si. sLL- 1976).
Muscles in general responded to denervation by lowering
their weight. With clenbuterol administration, however,
their weight was resumed. In the muscles examined, EDL had
no response. Soleus responsed only when the dose was high
enough and the period of administration was long enough.
Increased weight of soleus and gastrocnemius and the lesser
degree of response of EDL after clenbuterol administration
had also been reported by other groups (Reeds££. aJL., 1986;
Maltin et aJL«, 1987a). The fact that the least effect was
found in EDL may reflect that type II fibers has a low'
response to clenbuterol. This is consistent with the
finding that responses in slow twitch oxidative (type I)
fibers to clenbuterol were particularly marked (Maltin
et al.. 1986b). It has also been shown that fast twitch
muscle was physiologically insensitive to catecholamine
In vivo (Festoff£.!• r 1977).
The major difference among various types of fibers is
mainly in the energy source or the metabolic patterns. The
diverse effect of clenbuterol on different types of muscle
may also be significant in muscle metabolism. Moreover,
denervation caused changes in metabolism of skeletal
muscles. On the other hand, a number of metabolic and
physiological processes in skeletal muscle has been reported
to be influenced by 3-adrenergic stimulation, including
glycolysis, glucose uptake, and under some conditions
contractility and membrane potential (Drummond sJl 1.., 1969;
Flatman and Clausen, 1979; Reddy and Engel, 1979; Buur
sLL« 1982; Richter §1.., 1982). Thus, it is quite
possible that clenbuterol affect the growth of the muscles
through a variety of mechanism. Therefore, it is valuable
to assay the effect of clenbuterol on muscles.
For MDH activity, denervation lowered its activity in
the muscles examined except in adult gastrocnemius where an
increase has been observed. The effect of clenbuterol is
mainly opposite to that of denervation with the exception of
the chronically treated adult soleus. The decreased MDH
activity in denervated muscles agrees to the reported result.
(Simard aJu-, 1985). The effect of clenbuterol on
denervated muscles might indicate a metabolic basis for the
reversal of denervation induced. The diminished effect of
chronic clenbuterol treatment on soleus illustrates that
there may be a desensitization effect in skeletal muscles
after long term administration of the drug. This
desensitization effect has been reported to occur in the
central nervous system (Frazer al.., 1986) and peripheral
system (Bruynzeel, 1984).
It is surprised to find that the response of LDH
activity to the treatment is similar to that of MDH,
Denervation decreased the LDH activity in all the muscles
tested while clenbuterol reversed its effect. LDH activity
increased in the soleus after acute denervation. This shows
that the effect is fiber type dependent. Slow twitch
muscles which utilize mainly the energy from oxidative
metabolism increased its glycolytic activity after
denervation. However, the enzyme activity decreased as the
period of denervation was lenghtened. The decreased LDH
activities in the muscles examined agree to the finding in
three week denervated muscle (Simard £t al., 1985).
Clenbuterol effect on denervated adult fast twitch
muscles can only be obvious in rats with acute treatment.
Perhaps the effect of clenbuterol on fast twitch muscle can
last for only a short period, in young rats, only EDL did
not respond to clenbuterol treatment. With denervation and
clenbuterol administration soleus showed similar pattern in
all the situation tested except that of acute treatment. It
seems that the slow twitch fibers is the target of the
clenbuterol effect. The high response of young gastroc¬
nemius may be caused by the fact that being not fully
developed the ratio of slow twitch fibers is still rather
large.
The effect of another -adrenergic agonist,
isoproterenol, has been determined in skeletal muscle (Li
and Jefferson, 1977). It was found that oxidative
metabolism and lactate production increased in isolated rat
hemicorpus after perfusion with this drug. In our
experiment, however, increased oxidative metabolic activity
was found only in control EDL with clenbuterol treatment.
No glycolytic activity was found to be increased in the
control muscles after clenbuterol treatment. The
incompatibility of these results may be caused by the fact
that the in. vivo effect was reported in our experiment
whereas in the jji vitro experiment, the dose of drug
encountered by the muscle is usually much higher.
As a conclusion, it seems that clenbuterol has an
effect on denervation caused metabolic changes and thus the
ameliorative effect of the drug on denervated muscles has a
metabolic basis. Since there is no adrenergic structure at
the neuromuscular junction, the function of clenbuterol can
only be achieved through blood transportation or modulation
of the cholinergic activity at the junction (Beani et al..
1985). Therefore, the specific effects of clenbuterol on
denervated muscle may be caused by the fact that the effect-
through cholinergic modulation is no longer available in
denervated muscles. The metabolic pattern in clenbuterol
treated denervated muscle may be restored at least partially
to the normal one. However, the amino acid
aminotransferases activity has not been assayed in our
experiment and it is not clear if amino acids are still the
major energy source after clenbuterol treatment. But as the
LDH and MDH activities has been restored nearly to their
control level, the importance of amino acids as the energy
source must be lowered. It still cannot be concluded
whether the effect of clenbuterol on liver weight is a
direct effect of the drug or a consequence of the metabolic
changes in the skeletal muscles.
A clue to this problem can be obtained indirectly by
assaying the proteolytic activities in clenbuterol treated
muscles. If clenbuterol declines the increased proteinase
activities induced by denervation, the supply of amino acids
as the energy source will be limited. Also, as denervation
atrophy is a result of increased protein degradation in
skeletal muscles (Goldberg, 1969b), the ameliorative effect
may be a consequence of restoring the proteinase activities.
Although the restoration effect of clenbuterol on denervated
muscles was reported to be contributed mainly by a large
increase in protein synthesis, a significant portion of this
effect is still contributed by reduced degradation (Maltin
et a 1.. 1987b). Thus it is actually possible that
clenbuterol lowered the proteinase activities in denervated
muscles.
Acid proteinase and cathepsin B were studied in our
experiments. Acid phosphatase, being representative of
lysosomal activities, was also studied. It was reported
that clenbuterol promoted the growth of normal muscle in
young rats (Maltin et. gj,.., 1986a). The effect of
clenbuterol in control muscle of adult and young rats was
investigated. In the muscles examined, a significant effect
was found only in adult soleus with long term clenbuterol
treatment. However, this provides the biochemical basis for
the finding that the drug had an inhibitory effect on
protein degradation in normal muscle (Reeds e£. aj.., 1986).
For the proteinases studied, all increased their
activities in denervated muscles. This agrees to the
results in various reports (McLaughlin§£, 1974; Maskrey
et al.. 1977). Clenbuterol treatment had an effect on the
proteinase activities in denervated muscles. Clenbuterol
restored the denervation induced higher proteinase
activities in only EDL and young gastrocnemius only.
However, it has been reported that the effect of clenbuterol
in slow twitch oxidative (type 1) fibers was particularly
marked (Maltin et §2.., 1986b). This seems to be
contradictory to our findings.
The discrepancy between these results may give some
information about the mechanism of the effect of clenbuterol
on denervated muscles. Maltin (1987b) has shown that
clenbuterol induces growth in innervated and denervated rat
soleus muscle via different mechanisms. They suggested that,
clenbuterol exerts its effect by elevating the protein
synthetic activity in denervated soleus but decreases the
protein degradation in innervated muscle. Our result may
suggest that clenbuterol fulfills its function in different
type of denervated muscles through diverse mechanisms. In
the slow twitch muscle, a higher protein synthesis rate
corresponds to amelioration of the denervation induced
atrophy while in the fast twitch muscle, a decreased level
of protein degradation was the explanation.
Since -adrenergic agonist exerts its function through
the 3-adrenergic receptors, the differential effect of
clenbuterol on different denervated muscles may be caused by
a difference of the receptor in the muscles. It has been
reported that -adrenergic receptor density and
isoproterenol-stimulated adenylate cyclase activity were
considerably greater in the slow-twitch oxidative soleus
muscle than in the mixed fiber type gastrocnemius (Williams
et al.. 1984). So, it is not surprise to find that soleus
has a higher response to clenbuterol. On the other hand, It
has been reported that the maximum number of -adrenergic
binding sites increased in young gastrocnemius after 25 days
of denervation (Banerjee et. al.. 1977). This also agrees
well with our results in which young gastrocnemius was found
to be significant in restoring the denervation induced
change after clenbuterol treatment. However, the question
to ask is whether denervation has different effects on the
3-adrenergic receptors in different types of muscles.
It has been reported that the slow-twitch muscle
adenylate cyclase activities which was usually activated by
3-agonist were completely and permanently lost on
denervation. In fast twitch muscle, however, the enzyme
activities recovered almost completely after an initial
reduction (Festoff gt. 1 1977). This illustrates that
denervated fast muscles will respond to 3-therapy
differently from the denervated slow muscles. The higher
response of slow twitch muscles may be a consequence that
addition of 3-agonist compensates the lower adenylate
cyclase activity after denervation to maintain the normal
function of 3-st imulat ion on this muscle. As it seems that
denervation functions on fast twitch muscle not through the
effect on -stimulation, it is reasonable that 3-therapy has
no effect on denervation induced atrophy in fast twitch
muscles.
As the membranous organelles in denervated muscles were
found to be enlarged under the electronmicroscope
(Pellegrino and Franzini, 1963; Stonnington and Engel-,
1973), it was suspected that if lipid peroxidation was
involved in the denervation process. It was because that
increased lipid peroxidation will cause damage to the
membranous structures.
In the reports concerned so far, level of lipid
peroxide in denervated muscle has not been 'studied. For
this reason, amount of lipid peroxides in denervated and
clenbuterol treated muscle were determined in our
experiment. Malonaldehyde (MAD) or generally referred to as
the thiobarbituric acid-reactive product was used as an
index of the level of lipid peroxides in muscle homogenates.
In all the muscles studied, no change in MAD level was
found. This may imply that there was no accumulation of
lipid peroxides in the muscles examined.
Another way to investigate the involvement of lipid
peroxidation in denervation induced damage is to determine
the activities o£ the enzymes involved in scavenging the
free radicals. Change in MnSOD activity was not found in
both the denervated and clenbuterol treated muscles.
CuZnSOD activity as well as total SOD activity increased
only in young gastrocnemius and adult EDL after denervation.
Clenbuterol restored the denervation caused change to its
control level.
Since MnSOD is located in the matrix of mitochondria,
its concentration is usually used as an indicator of the
number of mitochondria in muscle (Mizuno, 1984). MnSOD
concentration also reflects mitochondrial free radical
production and this is in turn a function of mitochondrial
metabolic activity (Asayama ai.., 1986). The stable MnSOD
concentration in the muscles examined may imply an unchanged
mitochondrial metabolic activity. However, this is contrary
to the change of MDH activity which represents the
mitochondrial activity in our experiment. Also, the result
of MnSOD we obtained differs from that of Asayama e£ al.
(1986). They found a decreased MnSOD activity in denervated
muscle.
Increased CuZnSOD activity can be found only in the
denervated fast twitch muscles. Clenbuterol reversed this
effect. This pattern of clenbuterol influence is similar to
that of the proteinases assayed. So, a muscle type specific
effect was also observed. The increased CuZnSOD activity in
denervated muscles suggest an increased turnover of active
oxygen species. As CuZnSOD is a cytosolic enzyme, the
higher activity implies that the oxygen species have a
cytosolic or extracellular origin. Our result is, however.,
opposite to that of Asayama e£. al.. (1986). They found a
mild decreased CuZnSOD activity in slow twitch muscle. The
different result may be an outcome of the different methods
employed. They measured the immunoreactive activities while
we measure the ability of the enzyme to inhibit the
autoxidation of epinephrine.
The similar pattern of proteinases and CuZnSOD activity
in muscles after clenbuterol treatment shows CuZnSOD may be
related to the lysosomal activities in skeletal muscle.
However, the. significance of this relation is not clear'.
Perhaps more free radicals are produced in the denervated
muscles and then induced a higher CuZnSOD activity. The
free radicals raised by denervation may function on proteins
and thus make them more susceptible to the degradation of
proteinase. It has been shown that oxidized proteins were
more susceptible to proteolytic activities (Rivett and
Levine, 1987).
Contrast to the result of SOD, catalase activity
increased in all denervated muscles. Clenbuterol treatment,
usually lowers this activity in denervated muscle. If
catalase can actually be used as an enzymatic indicator of
the degree of muscle wasting as suggested by Stauber al.
(1977), then our result can be explained by that denervation
causes muscle degeneration and thus increases catalase
activity but clenbuterol treatment reverses the wasting
process and thus lowers the catalase activity. However, the
diverse effect of clenbuterol on different type of muscles
cannot be found. This may reflect that catalase activity is
much more sensitive to muscle atrophy than the gross change.
Thus although SOD and catalase are closely related their
activity is not necessary to respond to operation and drug
treatment similarly. The reason for the increase of
catalase activity in denervated muscle is not clear. It may
be an actual increase of production of the enzyme in
denervated muscles or a consequence of invasion of other
cells which contains catalase.
For the time effect investigated, decreased clenbuterol
response was found only in a few enzyme activities in the
two week treated rats. So, it is rather unlikely that
desensitization occurred during clenbuterol treatment.
However, a treatment of longer time may have this effect.
This is worth studying in the future.
As a conclusion, by examining the weight it was found
that EDL did not respond to clenbuterol treatment. For
energy metabolizing enzymes, the same pattern was shown in
both LDH and MDH activities, with the differences in the
response of different muscles types. All muscles showed the
same response to denervation and clenbuterol treatment in
MDH activity. For LDH activity, fast twitch muscle did not
respond to clenbuterol treatment. As LDH determines the
glycolytic activity, lower LDH activity in fast twitch
muscle made it short of energy supply. The insensitivity of
fast twitch muscle to clenbuterol in restoring its LDH
activity may be explained that EDL atrophy goes on even
after the institution of clenbuterol treatment.
For proteinases and SOD, all respond to denervation by
increasing their activities but only the fast twitch muscles
showed response to clenbuterol treatment. Thus, it was
suggested that clenbuterol effected its functions in
different muscle types through diverse mechanisms. That in
the slow twitch muscles may depend on the 3-adrenergic
system. Pattern of catalase activity with the treatment was
the same in all the muscles. As its pattern did not agree
to that of the other free radical scavenging enzymes, its
function was not clear.
It has been shown that another -adrenergic agonist,
isoproterenol, also decreased protein breakdown in skeletal
muscle (Li and Jefferson, 1977). Also, drugs of 3-agonist
group such as fenoterol and cimeterol have also been
reported to have muscle specific anabolic action (Maltin
et al.. 1987b). Thus it is valuable to determine the effect
of these 3-agonists on skeletal muscles. This may be
helpful to clarify the effect 3-agonist agonists on muscle
growth.
On the other hand, Maltin et. 1.. (1987a) has reported
that 3-antagonist, propranolol, did not lower the ability of
clenbuterol to stimulate protein accretion but reduced the
increase in muscle fiber size. They found that 3-agonist
did not impair the ability of clenbuterol to stimulate
muscle growth but significantly reduced the effects of 3-
agonist on body fat and, perhaps more importantly on total
energy expenditure. They suggested that although some of
the effects of clenbuterol are truly 3-mediated, the
particular effects of this drug on muscle protein accretion
bear little if any relationship to its action as a B-
agonist. Therefore, by investigating the effect of other B-
agonists and the effect of clenbuterol together with B-
antagonists will give a clearer picture of the function of
clenbuterol on muscle growth. The function of -adrenergic
receptors in skeletal muscle can thus also be clarified.
The effects of clenbuterol investigated so far are
mainly that on the enzyme activities. However, since
clenbuterol shows effect on growth of animals, it is
probably that hormones involved in growth may also
participate in the clenbuterol induced effect. It has been
reported that growth hormone increased protein synthesis in
muscle without changing protein degradation rates (Goldberg,
1969a). This effect is quite similar to thatof clenbuterol
on denervated muscle as reported by Maltin (1987b). On the
other hand, insulin has effects on muscle growth and
maintenance and it has been that functions of insulin on
skeletal muscle decrease after denervation (Burant et al..
1984; Smith and Lawrence, 1984; Smith and Lawrence, 1985;
Donalson and Harrison, 1986; Smith ejt aJL., 1988). It is
possible that denervation lowers the hormone response of
muscle and causes the atrophy while clenbuterol increase the
hormone concentration or the hormone response of denervated
muscles to ameliorate the denervation caused effect. Emery
et al. (1984) has reported that clenbuterol did not affect
plasma insulin, growth hormone, or triiodothyronine levels
in rats. So, it is also valuable to test the effect of
clenbuterol on the hormone response of skeletal muscles.
CHAPTER 5 GENERAL DISCUSSION
In this study, the muscle enzyme activities in two
animal models of muscle atrophy were investigated.
Atrophy of denervated muscle was assessed by the
decreased weight while that of the muscle in ethanol treated
rat was confirmed by the increase in alkaline phosphatase
activity in the muscles.
By examining the energy metabolizing enzymes, after
ethanol treatment, gastrocnemius was found to be dependent
more on oxidative metabolism. EDL did not show a shift ..in
metabolic activities. Soleus, however, shifted its
metabolic pattern from that of oxidative to anaerobic
glycolysis. In denervated muscles, all decreased the
activities of enzymes of glycolysis and citric acid cycle.
The different energy metabolizing enzyme patterns of these
two forms of muscle atrophy indicate rather different
mechanisms in these atrophying muscles. When clenbuterol
was administrated to denervated animals, it resumed the
denervation induced decrease in HDH activity in all muscles
and LDH in slow twitch muscles. As slow twitch muscle
obtains its energy mainly from oxidative metabolism, the
fact that glycolytic enzyme activity but not that of
oxidative metabolism was restored in clenbuterol treated
muscles shows that the metabolic change in denervated
muscles is a consequence of other changes, such as an
increased proteolytic activities. Both ethanol and
clenbuterol treatment showed a muscle type specific effect.
For the proteinases examined, their activity increased
in all muscles undergoing atrophy although in ethanol
treated rat the effect was not significant. The result in
ethanol treated rat suggests that probably proteinases other
than the acidic proteinases which were studied in our
experiment were involved in this form of muscle
degeneration. Clenbuterol has its effect on proteinase
activities only in the normal soleus and the denervated fast
twitch muscles. This result agrees to the finding of Maltin
et aT. (1987b) that clenbuterol decreases protein
degradation .in normal soleus but not in denervated soleus.
It also suggests that clenbuterol exerts its action in
different types of denervated muscles through diverse
mechanism. It decreases proteinase activities in denervated
fast twitch muscle but increase the protein synthesis in
denervated slow twitch muscle.
As calpain activity has been reported to be increased
in denervated muscle (Elce et. a.. 1983) and the increased
activity was mainly found in fast twitch muscle (Hussain
et al., 1987), it is interesting to investigate whether
clenbuterol has a fast twitch muscle specific effect on its
calpain activity. The results of the ethanol treated rat
revealed that the atrophy in these muscles is still at a
early stage and the extent is still not quite serious. This
is because calpain is believed to function at the early
stage of muscle atrophy for its neutral optimum pH and its
ability to degrade Z-line (Otsuka et. al.. 1988). Acidic
proteinase are believed to function only when the atrophy
has further developed to a more advanced because they can
degrade only the disassembled myofibrils and function in the
non-physiological acidic environment (Schwartz and Bird,
1977; Katunuma and Noda, 1982; Matsukura et al.. 1984).
Muscle type specific effects were also observed in the
free radical scavenging enzyme activities. For alcoholic
myopathy, only fast twitch muscles showed altered activity
in response to the treatment. However, it was soleus which
underwent atrophy. Therefore, it seems that the lacking in
adaptation to the increased free radical production renders
the slow twitch muscle susceptible to the free radical
damage.
Catalase and SOD activities showed different change
after denervation and clenbuterol treatment. CuZnSOD
activity did not change in slow twitch muscle. This
activity increased in denervated slow twitch muscle and
clenbuterol reversed this change. The different change of
CuZnSOD activity in slow and fast twitch muscles also
suggests different mechanism of neural control. The
elevated CuZnSOD activity in denervated muscles suggests a
higher turnover of active oxygen species and the situation
in clenbuterol treated muscle suggests the turnover rate has
been restored to the normal level. However, catalase
activity shows a peculiar sole pattern in the clenbuterol
treated denervated muscles. It is not certain at the moment
what the altered catalase activity implies.
By examining the result of clenbuterol treated muscles,
it is found that clenbuterol has its effect on both normal
and denervated slow twitch muscles but only in denervated
fast twitch muscles. It is proposed that in slow twitch
muscle part of the normal function is maintained through the
3-adrenergic system. While in denervated muscles, without
the control of the cholinergic system, the effect of the B-
adrenergic system is predominates.
Besides protein degradation and lipid peroxidation,
there is another system which may be related to the damage
seen in muscle atrophy. This system involves prostaglandins
and arachidonic acid. It has been shown that they are
involved in regulation of protein turnover in skeletal
muscles (Rodemann and Goldberg, 1982; Barnett and Ellis,
1987; Reeds et. al.. 1987). It is quite possible that the
treatment disturbs the regulation of this system and thus
change the balance of protein turnover, thus causing the
damage. Therefore, it would be valuable to detect the
activities of components of this system in the myopathy
mode Is.
The normal function of skeletal muscle is also
maintained by hormones such as insulin. It has also been
reported that response to insulin decreased in denervated
muscles (Burant et. aL., 1984; Smith and Lawrence, 1985;
Smith et aJU, 1988). It is quite possible that the lacking
in sensitivity to this hormone in the diseased muscles
triggers the atrophy process. It would therefore be
informative to determine the effect of this and other
hormones in the normal and atrophying muscles.
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